Back to GetFilings.com



Table of Contents



UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-K

     
þ
  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
    For the fiscal year ended December 31, 2003
 
or
 
o
  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
    For the transition period from           to

Commission File Number 001-31574

AMERIGROUP Corporation

(Exact name of registrant as specified in its charter)
     
Delaware
  54-1739323
(State or Other Jurisdiction of Incorporation or Organization)   (I.R.S. Employer Identification No.)
 
4425 Corporation Lane, Virginia Beach, Virginia
(Address of principal executive offices)
  23462
(Zip Code)

Registrant’s telephone number, including area code:

(757) 490-6900

Securities registered pursuant to Section 12(b) of the Act:

     
Title of Each Class Name of Each Exchange on Which Registered


Common Stock, $.01 par value
  New York Stock Exchange

       Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes þ          No o

      Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this 10-K.     o

     Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).     Yes þ          No o

      The aggregate market value of common stock held by non-affiliates at June 30, 2003 was $765,154,561.

     The number of shares of common stock, $0.01 par value, outstanding as of March 2, 2004, was 24,631,252.

Document Incorporated by Reference

Part III of this Report incorporates by reference information from the definitive

Proxy Statement for the Registrant’s 2004 Annual Meeting of Stockholders



 


TABLE OF CONTENTS

                 
Page

         PART I.        
 Item  1.    Business     2  
 Item 2.    Properties     18  
 Item  3.    Legal Proceedings     19  
 Item 4.    Submission of Matters to a Vote of Security Holders     20  
         PART II.        
 Item  5.    Market for Our Common Equity and Related Stockholder Matters     22  
 Item 6.    Selected Financial Data     23  
 Item  7.    Management’s Discussion and Analysis of Results of Operations and Financial Condition     25  
 Item 7A.    Quantitative and Qualitative Disclosures About Market Risk     34  
 Item 8.    Financial Statements and Supplementary Data     47  
 Item  9.    Changes in and Disagreements with Accountants on Accounting and Financial Disclosure     71  
 Item 9A.    Controls and Procedures     71  
         PART III.        
 Item 10.    Directors and Executive Officers of the Company     71  
 Item 11.    Executive Compensation     71  
 Item 12.    Security Ownership of Certain Beneficial Owners and Management     72  
 Item 13.    Certain Relationships and Related Transactions     72  
 Item 14.    Principal Accountant Fees and Services     72  
         PART IV.        
 Item 15.    Exhibits, Financial Statement Schedules and Reports on Form 8-K     72  
 Amended and Restated Contract
 Amended and Restated contracts
 Amended and Restated Contracts
 Amendent 8.to the 2002 Contract
 Code of Ethics
 List of Subsidiaries
 Consent of KPMG
 Certification
 Certification
 Certification

1


Table of Contents

PART I.

 
Item 1. Business

Overview

      We are a multi-state managed health care company focused on serving people who receive health care benefits through publicly sponsored programs, including Medicaid, State Children’s Health Insurance Program, or SCHIP and FamilyCare. We believe that we are better qualified and positioned than many of our competitors to meet the unique needs of our target populations because of our focus on providing managed care to these populations, our medical management programs and our community-based education and outreach programs. Unlike many managed care organizations that attempt to serve the general commercial population, as well as Medicare and Medicaid populations, we are focused exclusively on the Medicaid, SCHIP and FamilyCare populations. We do not currently offer Medicare or commercial products. In general, as compared to commercial or Medicare populations, our target population is younger, accesses health care in an inefficient manner and has a greater percentage of medical expenses related to obstetrics, diabetes, circulatory and respiratory conditions. We design our programs to address the particular needs of our members, for whom we facilitate access to health care benefits pursuant to agreements with the applicable regulatory authority. We combine medical, social and behavioral health services to help our members obtain quality health care in an efficient manner. Our success in establishing and maintaining strong relationships with state governments, providers and members has enabled us to obtain new contracts and to establish a leading market position in many of the markets we serve. Providers are hospitals, physicians and ancillary medical programs that provide medical services to our members. Members are said to be “enrolled” with our health plans to receive benefits. Accordingly, our total membership is generally referred to as our enrollment. As of December 31, 2003, we provided an array of products to approximately 857,000 members in Texas, Florida, Maryland, New Jersey, the District of Columbia and Illinois.

      We were incorporated in Delaware on December 9, 1994 as AMERICAID Community Care by a team of experienced senior managers led by Jeffrey L. McWaters, our Chairman and Chief Executive Officer. From 1994 through 1995, we were involved primarily in financial planning, recruiting and training personnel, developing products and markets and negotiating contracts with various state governments. During 1996, we began enrolling Medicaid members in our Fort Worth, New Jersey and Chicago plans, and in 1997, we obtained a contract and began enrolling members in our Houston plan. In 1999, we began operating in Maryland and the District of Columbia, and obtained a contract and began enrolling members in our Dallas plan. Our operations in Maryland and the District of Columbia are the result of acquiring contract rights from Prudential Health Care. Effective January 1, 2003, we began operations in Florida as a result of an acquisition of PHP Holdings, Inc. and its subsidiary Physicians Health Plans, Inc., or PHP. In addition, in Texas, Florida, New Jersey and the District of Columbia, we have increased membership through acquisitions of Medicaid contract rights and related assets of other health plans in these service areas.

Market Opportunity

 
Emergence of managed care

      Health care in the United States has grown from a $27 billion industry in 1960 to a highly regulated market of approximately $1.6 trillion in 2002, an increase of 9.3% from 2001, according to the federal government’s Centers for Medicare & Medicaid Services, or CMS.

      CMS projects total U.S. health care spending to reach $3.4 trillion in 2013, growing at an average annual rate of 7.3% during the forecasted period of 2002 through 2013. In response to the dramatic increases in health care-related costs in the late 1960s, Congress enacted the Federal Health Maintenance Organization Act of 1973, a statute designed to encourage the establishment and expansion of care and cost management. The private sector responded to this legislation by forming health maintenance organizations, or HMOs. HMOs were intended to address the needs of employers, insurers, government entities and health care providers who sought a cost-effective alternative to traditional indemnity insurance. Since the establishment of HMOs, enrollment has increased more than twelve-fold from 6.0 million in 1976 to nearly 76.1 million in 2002. Over that time, many HMOs have been formed to focus on a specific or specialty population of health care such as commercial plans

2


Table of Contents

for employees, Medicare, Medicaid, dental care and behavioral health care. Additionally, HMOs have been formed in a variety of sizes, from small community-based plans to multi-state organizations.

      Despite these efforts to organize care delivery, the costs associated with medical care have continued to increase. As a result, it has become increasingly important for HMOs to understand the populations they serve in order to develop an infrastructure and programs tailored to the medical and social profiles of their members.

 
Medicaid, SCHIP and FamilyCare Programs

      Medicaid, a state-administered program, was enacted in 1965 to make Federal matching funds available to all states for the delivery of health care benefits to eligible individuals, principally those with incomes below specified levels who meet other state-specified requirements. Medicaid is structured to allow each state to establish its own eligibility standards, benefits package, payment rates and program administration under broad federal guidelines. By contrast, Medicare, in which we do not currently participate, is a program administered by the federal government and is made available to the aged and disabled. Some of the differences between Medicaid and Medicare are set forth below:

     
Medicaid Medicare


• state administered,
  • federally operated,
• state and matching federal funds,
  • federal funds only,
• average age of our members is 14,
  • average age of recipients is over 70,
• 27 million people in managed care in 2003,
  • 5 million people in managed care in 2003,
• prescription drug coverage, and
  • prescription drug coverage begins in 2006, and
• mandatory managed care in most states.
  • no mandatory managed care.

      We do not currently offer Medicare products or participate in the Medicare program. However, CMS has announced demonstration projects, which would allow HMOs to cover Medicare dual-eligible members to be reimbursed for the acute care medical cost currently funded by Medicare. The benefits for this program would be similar to the benefits provided by Medicaid for non-dual eligible members. If we decide to participate in any of the programs and are selected by CMS to participate, some of our revenue would be funded by Medicare.

      Most states determine threshold Medicaid eligibility by reference to other federal financial assistance programs, including Temporary Assistance to Needy Families, or TANF, and Supplemental Security Income, or SSI.

      TANF provides assistance to low-income families with children and was adopted to replace the Aid to Families with Dependent Children program. SSI is a federal program that provides assistance to low-income aged, blind or disabled individuals. However, states can broaden eligibility criteria.

      SCHIP, developed in 1997, is a federal/state matching program that provides health care coverage to children not otherwise covered by Medicaid or other insurance programs. SCHIP enables a segment of the large uninsured population in the United States to receive health care benefits. States have the option of administering SCHIP through their Medicaid programs. SCHIP enrollment reached 5.8 million in fiscal 2003, an approximate 9% increase over 2002 enrollment figures.

      FamilyCare programs have been established in several states including New Jersey and the District of Columbia. The New Jersey FamilyCare Health Coverage Act is a Medicaid expansion program providing health care access to an estimated 64,000 previously uninsured or underinsured New Jersey residents in fiscal 2004. New Jersey FamilyCare is a voluntary federal and state-funded health insurance program created to help uninsured families, single adults and couples without dependent children obtain affordable health care coverage. The FamilyCare program in the District of Columbia provides services to approximately 98,000 primarily low-income pregnant women, children and adults in fiscal 2004.

      Nationally, approximately 62% of Medicaid spending is directed toward hospital, physician and other acute care services, and the remaining approximately 38% is for nursing home and other long-term care. In general, inpatient and emergency room utilization tends to be higher within the Medicaid population than among the

3


Table of Contents

general population because of the inability to afford access to a primary care physician, or PCP, leading to the postponement of treatment until acute care is required.

      The highest health care expenses for the non-elderly and disabled Medicaid population include:

  •  obstetrics,
 
  •  respiratory illness,
 
  •  diabetes,
 
  •  neonatal care,
 
  •  sickle cell disease, and
 
  •  HIV/ AIDS.

      In fiscal year 2003, the federal government spent approximately $161 billion on Medicaid and states spent an additional approximately $121 billion. Federal government estimates indicate that total Medicaid outlays may reach approximately $311 billion for fiscal year 2004, with an additional approximately $5.2 billion spent on SCHIP programs. Key factors driving Medicaid spending include:

  •  number of eligible individuals who enroll,
 
  •  price of medical and long-term care services,
 
  •  use of covered services,
 
  •  state decisions regarding optional services and optional eligibility groups, and
 
  •  effectiveness of programs to reduce costs of providing benefits, including managed care.

 
Medicaid Funding

      The federal government pays a share of the medical assistance expenditures under each state’s Medicaid program. That share, known as the Federal Medical Assistance Percentage, or FMAP, is determined annually by a formula that compares the state’s average per capita income level with the national average per capita income level. Thus, states with higher per capita income levels are reimbursed a smaller share of their costs than states with lower per capita income levels. The FMAP cannot be lower than 50% or higher than 83%. In 2003, the FMAPs varied from 50% in 13 states and five territories to 76.6% in Mississippi, and 57% overall. In addition, the Balanced Budget Act of 1997 permanently raised the FMAP for the District of Columbia from 50% to 70%. The states’ fiscal 2004 FMAPs for the markets in which we have contracts are:

         
State FMAP


New Jersey
    50.0 %
Texas
    60.2 %
Maryland
    50.0 %
Illinois
    50.0 %
District of Columbia
    70.0 %
Florida
    58.9 %

      The federal government also matches administrative costs, generally about 50%, although higher percentages are paid for certain activities and functions, such as development of automated claims processing systems. Federal payments have no set limits (other than for SCHIP programs), but rather are made on a matching basis. In 2002, 43% of total federal funds provided to states were spent on Medicaid, the highest category of federal funds provided to states.

      State governments pay the share of Medicaid and SCHIP costs not paid by the Federal government. Some states require counties to pay part of the state’s share of Medicaid costs. In 2002, Medicaid was the second largest

4


Table of Contents

category of state spending, following spending on elementary and secondary education, and made up over 21% of total state spending.

      Federal law establishes general rules governing how states administer their Medicaid and SCHIP programs. Within those rules, states have considerable flexibility, including flexibility in how they set most provider prices and service utilization controls. Generally, state Medicaid budgets are developed and approved annually by the states’ governors and legislatures. Medicaid expenditures are monitored during the year against budgeted amounts. Federal law requires states to offer at least two HMOs in any urban market with mandatory HMO enrollment. If Medicaid HMO market departures result in only one or no HMOs in an urban area, the affected state must also offer the fee-for-service Medicaid program.

      Under the Health Insurance Flexibility and Accountability Demonstration Program (HIFA), states can seek waivers from specific provisions of federal Medicaid requirements to increase the number of individuals with health coverage through current Medicaid and SCHIP resource levels. Currently, eight states are involved in either approved waiver programs or pending applications. The current federal administration has emphasized providing coverage to populations with income below 200 percent of the federal poverty level.

 
Medicaid Managed Care

      Historically, the traditional Medicaid programs made payments directly to providers after delivery of care. Under this approach, recipients received care from disparate sources, as opposed to being cared for in a systematic way. As a result, care for routine needs was often accessed through emergency rooms or not at all.

      The delivery of episodic health care under the traditional Medicaid program limited the ability of the states to provide quality care, implement preventive measures and control health care costs. Over the past decade, in response to rising health care costs and in an effort to ensure quality health care, the federal government has expanded the ability of state Medicaid agencies to explore, and, in some cases, mandate the use of managed care for Medicaid beneficiaries. If Medicaid managed care is not mandatory, individuals entitled to Medicaid may choose either the traditional Medicaid program or a managed care plan, if available. According to information published by CMS, from 1993 to 1998 managed care enrollment among Medicaid beneficiaries increased more than three-fold. All the markets in which we operate, except Illinois, have state-mandated Medicaid managed care programs in place.

The AMERIGROUP Approach

      Unlike many managed care organizations that attempt to serve the general population, as well as Medicare and Medicaid populations, we are focused exclusively on serving people who receive health care benefits through publicly sponsored programs. We do not currently offer Medicare or commercial products. Our success in establishing and maintaining strong relationships with state governments, providers and members has enabled us to obtain new contracts and to establish a strong market position in the markets we serve. We have been able to accomplish this by addressing the various needs of these constituent groups.

 
State Governments

      We have been successful in bidding for contracts and implementing new products because of our ability to facilitate access to quality health care services in a cost-effective manner. Our education and outreach programs, our disease and medical management programs and our information systems benefit the communities we serve while providing the state governments with predictability of cost. Our education and outreach programs are designed to decrease the use of emergency care services as the primary access to health care through the provision of programs like member health education seminars and system-wide 24-hour on-call nurses. Our information systems are designed to measure and track our performance enabling us to demonstrate the effectiveness of our programs to the government. While we promote ourselves directly in applying for new contracts or seeking to add new benefit plans, we believe that our ability to obtain additional contracts and expand our service areas within a state results primarily from our demonstration of prior success in facilitating access to quality care, while reducing and managing costs, and our customer-focused approach to working in partnership

5


Table of Contents

with state governments. We believe we will also benefit from this experience when bidding for and acquiring contracts in new state markets.
 
Providers

      In each of the communities where we operate, we have established extensive provider networks and have been successful in continuing to establish new provider relationships. We have accomplished this by working closely with physicians to help them operate efficiently by providing financial, statistical and utilization information, physician and patient educational programs and disease and medical management programs, as well as by adhering to a prompt payment policy. In addition, as we increase our market penetration, we provide our physicians with a growing base of potential patients in the markets they serve. This network of providers and relationships assists us in implementing preventive care methods, managing costs and improving access to health care for members. We believe that our experience working and contracting with Medicaid providers will give us a competitive advantage in entering new markets. While we do not directly market to or through our providers, they are important in helping us attract new members and retain existing members.

 
Members

      In both signing up new members and retaining existing members, we focus on our understanding of the unique needs of the Medicaid, SCHIP and FamilyCare populations. We have developed a system that provides our members with appropriate access to care. We supplement this care with community-based education and outreach programs designed to improve the well-being of our members. These programs not only help our members control and manage their medical care, but also have been proven to decrease the incidence of emergency room care, which is traumatic for the individual and expensive and inefficient for the health care system. We also help our members access prenatal care which improves outcomes for our members and is less costly than unmanaged care. As our presence in a market matures, these programs, and other value-added services, help us build and maintain membership levels.

 
Communities

      We focus on the members we serve and the communities where they live. Many of our associates, including the sales force and outreach staff, are a part of the communities we serve. We are active in our members’ communities through education and outreach programs. We often provide programs in our members’ physician offices, churches and community centers. Upon entering a new market, we use these programs and other advertising to create brand awareness and loyalty in the community.

Strategy

      Our objective is to become the leading managed care organization in the United States focused on serving people who receive health care benefits through publicly sponsored programs. To achieve this objective we intend to:

      Increase our membership in existing and new markets through internal growth and acquisitions. We intend to increase our membership in existing and new markets through development and implementation of community-specific products, alliances with key providers, sales and marketing efforts and acquisitions. We facilitate access to a broad continuum of health care supported by numerous services such as neonatal intensive care and high-risk pregnancy programs. These products and services are developed and administered by us but are also designed to attract and retain our providers, who are critical to our overall success. Through strategic and selective contracting with providers, we are able to customize our provider networks to meet the unique clinical, cultural and socio-economic needs of our members. Our providers often are located in the inner-city neighborhoods where our members live, thereby providing accessibility to, and an understanding of, the needs of our members. For example, in our voluntary Chicago market, we have a sales force to recruit potential members who are currently in the traditional fee-for-service Medicaid system. The overall effect of this comprehensive approach reinforces our broad brand-name recognition as a leading managed health care company serving people who receive publicly sponsored health care benefits, while complying with state-mandated marketing guidelines.

6


Table of Contents

We may also choose to increase membership by acquiring Medicaid contracts and other related assets from competitors in our existing markets. Since 1996, we have developed markets in Texas, New Jersey and Illinois and acquired additional Medicaid contracts and related assets in New Jersey, Texas, Florida, Maryland and the District of Columbia. We evaluate potential new markets using our established government relationships and our historical experience in managing Medicaid populations. Our management team is experienced in identifying markets for development of new operations, including complementary businesses, identifying and executing acquisitions and integrating these businesses into our existing operations. For example, in 2003, we began operations in Florida as a result of acquisitions of PHP and St. Augustine Medicaid, or St. Augustine, a division of AvMed, Inc., resulting in approximately 219,000 members in the Miami/ Fort Lauderdale, Orlando and Tampa markets.

      Capitalize on our experience working in partnership with state governments. We continually strive to be an industry-recognized leader in government relations and an important resource to our state government customers. For example, we have a dedicated legislative affairs team with experience at the federal, state and local levels. We are, and intend to continue to be, an active and leading participant in the formulation and development of new policies and programs for publicly sponsored health care benefits. This also enables us to competitively expand our service areas and to implement new products.

      Focus on our “medical home” concept to provide quality, cost-effective health care. We believe that the care the Medicaid population has historically received can be characterized as uncoordinated, episodic and short-term focused. In the long-term, this approach is less desirable for the patient and more expensive for the state.

      Our approach to serving the Medicaid and historically uninsured populations is based on offering a comprehensive range of medical and social services intended to improve the well-being of the member while lowering the overall cost of providing benefits. Unlike traditional Medicaid, each of our members has a primary contact, usually a PCP, to coordinate and administer the provision of care, as well as enhanced benefits, such as 24-hour on-call nurses. We refer to this coordinated approach as a “medical home”.

      Utilize population-specific disease management programs and related techniques to improve quality and reduce costs. An integral part of our medical home concept is continual quality management. To help the physician improve the quality of care and improve the health status of our members, we have developed a number of programs and procedures to address high frequency, chronic or high-cost conditions such as pregnancy, respiratory conditions, diabetes, sickle cell and congestive heart failure. Our procedures include case and disease management, pre-admission certification, concurrent review of hospital admissions, discharge planning, retrospective review of claims, outcome studies and management of inpatient, ambulatory and alternative care. These policies and programs are designed to consistently provide high quality care and cost-effective service to our members.

Products

      We have developed several products through which we offer a range of health care services. These products are also community-based and seek to address the social and economic issues faced by the populations we serve. Additionally, we seek to establish strategic relationships with prestigious medical centers, children’s hospitals and federally qualified health centers to assist in implementing our products and medical management programs within the communities we serve. Our health plans cover various services that vary by state and may include:

  •  primary and specialty physician care,
 
  •  inpatient and outpatient hospital care,
 
  •  emergency and urgent care,
 
  •  prenatal care,
 
  •  laboratory and x-ray services,
 
  •  home health and durable medical equipment,
 
  •  behavioral health services and substance abuse,

7


Table of Contents

  •  long-term and nursing home care,
 
  •  24-hour on-call nurses,
 
  •  vision care and exam allowances,
 
  •  dental care,
 
  •  chiropractic care,
 
  •  podiatry,
 
  •  prescriptions and limited over-the-counter drugs,
 
  •  assistance with obtaining transportation for office or health education visits,
 
  •  memberships in the Boys and Girls Clubs, and
 
  •  welcome calls and health status calls to coordinate care.

      Our products, which we may offer under different names in different markets, focus on specific populations within the Medicaid, FamilyCare and SCHIP programs. The average premiums for our products vary significantly due to differences in the benefits offered and underlying medical conditions in the populations covered.

      AMERICAID, our principal product, is our family-focused Medicaid managed health care product designed for the TANF population that consists primarily of low-income children and their mothers. We currently offer our AMERICAID product in all markets we serve. As of December 31, 2003, we had approximately 587,000 AMERICAID members.

      AMERIKIDS is our managed health care product for uninsured children not eligible for Medicaid. This product is designed for children in the SCHIP initiative. We began offering AMERIKIDS in Maryland and Washington, D.C. when we acquired Prudential’s contract rights and other related assets in those areas in 1999. We began offering AMERIKIDS in New Jersey and Texas in 2000 and Chicago in 2003. We began offering AMERIKIDS in Florida when we acquired PHP’s contract rights and other related assets in 2003. As of December 31, 2003, we had approximately 180,000 AMERIKIDS members.

      AMERIPLUS is our managed health care product for SSI recipients. This population consists of the low-income aged, blind and disabled. We began offering this product in 1998 and currently offer it in New Jersey, Maryland, Houston and Florida. We expect our AMERIPLUS membership to grow as more states include SSI benefits in mandatory managed care programs. As of December 31, 2003, we had approximately 74,000 AMERIPLUS members. Included in this number are approximately 540 members added through a Florida program called Summit Care. Summit Care is a pilot program by the State of Florida to help seniors live safely in their homes as an alternative to nursing home care.

      AMERIFAM is our FamilyCare managed health care product designed for uninsured segments of the population other than SCHIP eligibles. AMERIFAM’s current focus is the families of our SCHIP and Medicaid children. We offer this product in Washington, D.C. and New Jersey where the program covers parents of SCHIP and Medicaid children. As of December 31, 2003, we had approximately 16,000 AMERIFAM members.

      As of December 31, 2003, of our 857,000 members, 91% were enrolled in TANF, SCHIP and FamilyCare programs. The remaining 9% were enrolled in SSI programs. Of these SSI enrollees, approximately 7,000 were members to whom we provided limited administrative services but did not provide health benefits.

Disease and Medical Management Programs

      We provide specific disease and medical management programs designed to meet the special health care needs of our members with chronic illnesses, to manage excessive costs and to improve the overall health of our members. We currently offer disease and medical management programs in areas such as neonatal, high-risk pregnancy, asthma and other respiratory conditions, congestive heart failure, sickle cell disease, diabetes and HIV. These programs focus on preventing acute occurrences associated with chronic conditions by identifying at-risk members, monitoring their conditions and pro-actively managing their care. We also employ tools such as

8


Table of Contents

utilization review and pre-certification to reduce the excessive costs often associated with uncoordinated health care programs.

Marketing and Educational Programs

      An important aspect of our comprehensive approach to health care delivery is our marketing and educational programs, which we administer system-wide for our providers and members. We often provide our educational programs in members’ homes and our marketing and educational programs in churches and community centers. The programs we have developed are specifically designed to increase awareness of various diseases, conditions and methods of prevention in a manner that supports the providers, while meeting the unique needs of our members. For example, we conduct health promotion events in physicians’ offices that target respiratory conditions, immunization and other health issues. Direct provider marketing is supported by traditional marketing venues such as direct mail, telemarketing, television, radio and cooperative advertising with participating medical groups.

      We believe that we can also increase and retain membership through marketing and education initiatives. We have a dedicated staff that actively supports and educates prospective and existing members and community organizations. Through programs such as Safe Kids, and Taking Care of Baby and Me®, a prenatal program for pregnant moms and their babies, we promote a healthy lifestyle, safety and good nutrition to our members. In addition to these personal health-related programs, we remain committed to the communities we serve.

      We have developed specific strategies for building relationships with key community organizations, which help enhance community support for our products and improve service to members. We regularly participate in local events and festivals and organize community health fairs to promote healthy lifestyle practices. Equally important, our associates help support community groups by serving as board members and volunteers. In the aggregate, these activities serve to act not only as a referral channel, but also reinforce the AMERIGROUP brand and foster member loyalty.

      In several markets, we provide value-added benefits as a means to attract and retain members. These benefits include free memberships to the local Boys and Girls Clubs and vouchers for over-the-counter medications. We believe that our comprehensive approach to health care positions us well to serve our members, their providers and the communities in which they both live and work.

Community Partners

      We believe community focus and understanding are important to attracting and retaining members. To assist in establishing our community presence in a new market, we seek to establish relationships with prestigious medical centers, children’s hospitals and federally qualified health centers to offer our products and programs. For example, we have a strategic relationship with Memorial Hermann Healthcare System in Houston, granting us the right to actively market their name and logo in advertising of our Medicaid products.

Provider Network

      We facilitate access to health care services to our members through mutually non-exclusive contracts with PCPs, specialists, hospitals and ancillary providers. Either prior to or concurrently with bidding for new contracts, we establish a provider network in each of our service areas. The following table shows the total number of PCPs, specialists, hospitals and ancillary providers participating in our network as of December 31, 2003:

                                                 
Service Areas

Texas New Jersey Maryland and D.C. Illinois Florida Total






Primary care physicians
    1,317       1,816       1,569       495       1,673       6,870  
Specialists
    4,322       4,560       6,626       1,083       5,306       21,897  
Hospitals
    63       71       47       21       96       298  
Ancillary providers
    667       552       342       423       882       2,866  

9


Table of Contents

      The PCP is a critical component in care delivery, and also in the management of costs and the attraction and retention of new members. PCPs include family and general practitioners, pediatricians, internal medicine physicians and OB/ GYNs. These physicians provide preventive and routine health care services and are responsible for making referrals to specialists, hospitals and other providers. Health care services provided directly by PCPs include the treatment of illnesses not requiring referrals, periodic physician examinations, routine immunizations, well child care and other preventive health care services.

      Specialists provide medical care to members generally upon referral by the PCPs. However, we have identified specialists that are part of the ongoing care of our members, such as allergists, oncologists and surgeons, which our members may access directly without first obtaining a PCP referral. Our contracts with both the PCPs and specialists usually are for one-to two-year periods and automatically renew for successive one-year periods subject to termination by us for cause, if necessary, based on provider conduct or other appropriate reasons. The contracts generally can be canceled by either party upon 90 to 120 days prior written notice.

      Our contracts with hospitals are usually for one-to two-year periods and automatically renew for successive one-year periods. Generally, our hospital contracts may be terminated by either party without cause with 90 to 150 days prior written notice. Pursuant to the contract, the hospital is paid for all pre-authorized medically necessary inpatient and outpatient services and all covered emergency and medical screening services provided to members. With the exception of emergency services, most inpatient hospital services require advance approval from the member’s PCP and our medical management department. We require hospitals in our network to participate in utilization review and quality assurance programs.

      We have also contracted with other ancillary providers for physical therapy, mental health and chemical dependency care, home health care, vision care, diagnostic laboratory tests, x-ray examinations, ambulance services and durable medical equipment. Additionally, we have contracted with dental vendors that provide routine dental care in markets where routine dental care is a covered benefit and with a national pharmacy benefit manager that provides a local pharmacy network in our markets where pharmacy is a covered benefit.

      In order to ensure the quality of our medical care providers, we credential and re-credential our providers using standards that are supported by the National Committee for Quality Assurance. Additionally, we provide feedback and evaluations on quality and medical management to them in order to improve the quality of care provided, increase their support of our programs and enhance our ability to attract and retain providers.

Provider Payment Methods

      Fee-for-Service. This is a reimbursement mechanism that pays providers based upon services performed. For the year ended December 31, 2003, approximately 93% of our expenses for direct health benefits were on a fee-for-service reimbursement basis, including fees paid to third-party vendors for ancillary services such as pharmacy, mental health, dental and vision benefits. The primary fee-for-service arrangements are maximum allowable fee schedule, per diem, case rates, percent of charges or any combination thereof. The following is a description of each of these mechanisms:

        Maximum Allowable Fee Schedule. Providers are paid the lesser of billed charges or a specified fixed payment for a covered service. The maximum allowable fee schedule is developed using, among other indicators, the state fee-for-service Medicaid program fee schedule, Medicare fee schedules, medical costs trends and market conditions.
 
        Per Diem and Case Rates. Hospital facility costs are typically reimbursed at negotiated per diem or case rates, which vary by level of care within the hospital setting. Lower rates are paid for lower intensity services, such as a low birth weight newborn baby who stays in the hospital a few days longer than the mother, compared to higher rates for a neonatal intensive care unit stay for a baby born with severe developmental disabilities.
 
        Percent of Charges. We contract with providers to pay them an agreed-upon percent of their standard charges for covered services. This is typically done where hospitals are reimbursed under the state fee-for-service Medicaid program on a percent of charges basis.

10


Table of Contents

      Capitation. Some of our PCPs and specialists are paid on a fixed-fee per member basis, also known as capitation. Our arrangements with ancillary providers for vision, dental, home health, laboratory, durable medical equipment, mental health and chemical dependency services may also be capitated.

      We review the fees paid to providers periodically and make adjustments as necessary. Generally, the contracts with the providers do not allow for automatic annual increases in payments. Among the factors generally considered in adjustments are changes to state Medicaid fee schedules, competitive environment, current market conditions, anticipated utilization patterns and projected medical expenses. In order to enable us to better monitor quality and meet our state contractual encounter reporting obligations, it is our intention to increase the number of providers we pay on a fee-for-service basis and reduce the number of capitation contracts we have. States use the encounter data to monitor quality of care to members and to set premium rates.

Our Health Plans

      We have five active health plan subsidiaries offering health care services in Texas, Florida, Maryland, New Jersey, the District of Columbia and Illinois. We expect our relationship with these jurisdictions to continue. Each of our health plans have one or more contracts that expire at various times, as set forth below:

         
Market Product Term End Date



Texas   TANF, SSI, SCHIP   August 31, 2004
Florida
  TANF, SSI, SCHIP   June 30, 2004(a)
Florida
  SCHIP   September 30, 2004(b) and 2005
Florida
  SSI (Summit Care)   June 30, 2005(c)
New Jersey
  TANF, SSI, SCHIP, FamilyCare   June 30, 2004
Maryland(d)
  TANF, SSI, SCHIP  
District of Columbia
  TANF, SCHIP, FamilyCare   July 31, 2004
Illinois
  TANF, SCHIP   July 31, 2004


 
(a) This contract can be terminated by either party upon 30 days notice.
 
(b) This contract covers approximately 13,000 members in two counties.
 
(c) This contract can be terminated by either party upon 60 days notice.
 
(d) Our Maryland contract does not have a set term.
 
Texas

      Our Texas subsidiary, AMERIGROUP Texas, Inc., is licensed as an HMO and became operational in September 1996. Our current service areas include the cities of Fort Worth, Dallas and Houston and the surrounding counties. As of December 31, 2003, we had approximately 343,000 members in Texas, consisting of approximately 144,000 members in Houston, approximately 93,000 members in Dallas and approximately 106,000 members in Fort Worth. Based on information available to us, we believe we have the largest Medicaid membership in each of our Fort Worth and Houston markets and the second largest Medicaid membership in our Dallas market. We offer AMERICAID in each of our Texas markets and AMERIPLUS in Houston. The Texas Health and Human Services Commission has selected AMERIGROUP Texas, Inc. to begin serving Medicaid recipients, effective May 1, 2004, in the Travis service area. Our TANF contract in Fort Worth, our TANF and SCHIP contracts in Dallas and our TANF, SCHIP and SSI contracts in Houston are set to expire on August 31, 2004; however, we expect the contracts to be extended through calendar year 2004. We plan to participate in a re-procurement process of all product contracts and all service areas in 2004 for an early 2005 effective date.

 
Florida

      Our Florida subsidiary, AMERIGROUP Florida, Inc., is licensed as an HMO and became operational in January 2003 with the acquisition of PHP. In July 2003, we acquired the Medicaid contract rights and related

11


Table of Contents

assets of St. Augustine. Our current service areas include the metropolitan areas of Miami/ Fort Lauderdale, Orlando and Tampa that include 13 counties in Florida. We did not have any membership for December 2002. As of December 31, 2003, we had approximately 221,000 members, consisting of approximately 47,000 members in Miami/ Fort Lauderdale, 42,000 members in Orlando and 132,000 members in Tampa. Based on information available to us, we believe we have the largest Medicaid membership in the Orlando and Tampa markets and the fourth largest Medicaid membership in our Miami/ Fort Lauderdale market. Our TANF, SSI and SCHIP contracts expire June 30, 2004 and can be terminated by either party upon 30 days notice. A new TANF contract will be issued for a July 1, 2004 effective date covering a two year span (through June 30, 2006). Our Summit Care contract expires June 30, 2005 and can be terminated by either party upon 60 days notice. As a result of a successful Florida SCHIP re-bid in 2003, individual county contracts were consolidated into one contract covering six counties effective through September 30, 2005. An additional two-county SCHIP contract will be re-bid this year for a two-year term effective October 1, 2004.
 
New Jersey

      Our New Jersey subsidiary, AMERIGROUP New Jersey, Inc., is licensed as an HMO and became operational in February 1996. Our current service areas include 20 of the 21 counties in New Jersey. As of December 31, 2003, we had approximately 99,000 members in New Jersey. Based on information available to us, we believe we have the third largest Medicaid membership in New Jersey. We offer AMERICAID, AMERIPLUS, AMERIKIDS and AMERIFAM in New Jersey. Our contract with the State of New Jersey expires on June 30, 2004 but will be extended by contract amendment for an additional year.

 
Maryland

      Our Maryland subsidiary, AMERIGROUP Maryland, Inc., a Managed Care Organization, is authorized to operate as a managed care organization in Maryland and became operational in June 1999. Our current service areas include 20 of the 24 counties in Maryland. As of December 31, 2003, we had approximately 124,000 members in Maryland. Based on information available to us, we believe we have the largest Medicaid membership in Maryland. We offer AMERICAID, AMERIPLUS and AMERIKIDS in Maryland. Our contract with the State of Maryland does not have a set term. We can terminate our contract with Maryland by notifying the State by October 1st of any given year for an effective termination date of January 1st of the following year. The State may waive this timeframe if the circumstances warrant, including but not limited to reduction in rates outside the normal rate setting process or an MCO exit from the program.

 
District of Columbia

      AMERIGROUP Maryland, Inc., a Managed Care Organization, is also licensed as an HMO in the District of Columbia and became operational there in August 1999. As of December 31, 2003, we had approximately 38,000 members in the District of Columbia. Based on information available to us, we believe we have the largest Medicaid membership in the District of Columbia. We offer AMERICAID, AMERIKIDS and AMERIFAM in the District of Columbia. Our contract with the District of Columbia extends through July 31, 2004, with the District’s option to continue contract extensions for additional one year terms through July 31, 2007.

 
Illinois

      Our Illinois subsidiary, AMERIGROUP Illinois, Inc., is licensed as an HMO and became operational in April 1996. Our current service area includes the counties of Cook and DuPage in the Chicago area. In Chicago, enrollment in a Medicaid managed care plan is voluntary. As of December 31, 2003, we had approximately 32,000 members in Chicago. Based on information available to us, we believe we have the second largest Medicaid health plan membership in Cook County. We offer AMERICAID and AMERIKIDS in the Chicago area. Our contract with the State of Illinois, which can be terminated by either party with 90 days written notice, extends through July 31, 2004, and includes an automatic renewal provision for two consecutive one-year terms, thereby extending the contract through July 31, 2006.

12


Table of Contents

Quality Management

      We have a comprehensive quality management plan designed to improve access to cost-effective quality care. We have developed policies and procedures to ensure that the health care services arranged by our health plans meet the professional standards of care established by the industry and the medical community. These procedures include:

  •  Analysis of health care utilization data. To avoid duplication of services or medications, in conjunction with the PCPs, health care utilization data is analyzed and, through comparative provider data and periodic meetings with physicians, we identify areas in which a physician’s utilization rate differs significantly from the rates of other physicians. On the basis of this analysis, we suggest opportunities for improvement and follow-up with the PCP to monitor utilization.
 
  •  Medical care satisfaction studies. We evaluate the quality and appropriateness of care provided to our health plan members by reviewing health care utilization data and responses to member and physician questionnaires and grievances.
 
  •  Clinical care oversight. Each of our health plans has a medical advisory committee comprised of physician representatives and chaired by the plan’s medical director. This committee reviews credentialing, approves clinical protocols and practice guidelines and evaluates new physician group candidates. Based on regular reviews, the medical directors who head these committees develop recommendations for improvements in the delivery of medical care.
 
  •  Quality improvement plan. A quality improvement plan is implemented in each of our health plans and is governed by a quality management committee. The quality management committee is comprised of senior management at our health plans, who review and evaluate the quality of our health services and are responsible for the development of quality improvement plans spanning both clinical quality and customer service quality. These plans are developed from provider and membership feedback, satisfaction surveys and results of action plans. Our corporate quality improvement council oversees and meets regularly with our health plan quality management committees to help ensure that we have a coordinated, quality-focused approach relating to our members, providers and state governments.

Management Information Systems

      The ability to access data and translate it into meaningful information is essential to our being able to operate across a multi-state service area in a cost-effective manner. Our centralized computer-based information systems support our core processing functions under a set of integrated databases. This integrated approach helps to assure that consistent sources of claim and member information are provided across all of our health plans. We use these systems for billing, claims processing, utilization management, marketing and sales tracking, financial and management accounting, medical cost trending, reporting, planning and analysis. The systems also support our internal member and provider service functions, including on-line access to member eligibility verification, PCP membership roster and claims status.

      We estimate that our current claims payment system could be at full capacity within the next 12 months. Accordingly, in November 2003, we signed a software licensing agreement with The Trizetto Group, Inc. for their Facets Extended EnterpriseTM administrative system (Facets). We currently expect that Facets will meet our software needs for an estimated ten years and will support our long-term growth strategies.

Competition

      Our principal competitors for state contracts, members and providers consist of the following types of organizations:

  •  Primary Care Case Management Programs, or PCCMs — Programs established by the states through contracts with PCPs to provide primary care services to the Medicaid recipient, as well as provide limited oversight over other services.

13


Table of Contents

  •  Commercial HMOs — National and regional commercial managed care organizations that have Medicaid and Medicare members in addition to members in private commercial plans.
 
  •  Medicaid HMOs — Managed care organizations that focus solely on serving people who receive health care benefits through Medicaid.

      We will continue to face varying levels of competition as we expand in our existing service areas or enter new markets. In Illinois, where enrollment in a managed care plan is voluntary, we also compete for members with the traditional means for accessing care, including hospitals and other health care providers. Health care reform proposals may cause a number of commercial managed care organizations already in our service areas to decide to enter or exit the Medicaid market. However, the licensing requirements and bidding and contracting procedures in some states present barriers to entry into the Medicaid managed health care industry.

      We compete with other managed care organizations to obtain state contracts, as well as to attract new members and to retain existing members. States generally use either a formal proposal process reviewing many bidders, or award individual contracts to qualified applicants that apply for entry to the program. In order to be awarded a state contract, state governments consider many factors, which include providing quality care, satisfying financial requirements, demonstrating an ability to deliver services, and establishing networks and infrastructure. People who wish to enroll in a managed health care plan or to change health care plans typically choose a plan based on the service offered, ease of access to services, a specific provider being part of the network and the availability of supplemental benefits.

      In addition to competing for members, we compete with other managed care organizations to enter into contracts with independent physicians, physician groups and other providers. We believe the factors that providers consider in deciding whether to contract with us include potential member volume, reimbursement rates, our medical management programs, timeliness of reimbursement and administrative service capabilities.

Regulation

      Our health care operations are regulated at both state and federal levels. Government regulation of the provision of health care products and services is a changing area of law that varies from jurisdiction to jurisdiction. Regulatory agencies generally have discretion to issue regulations and interpret and enforce laws and rules. Changes in applicable laws and rules may also occur periodically.

 
HMOs and MCOs

      Our five health plan subsidiaries are authorized to operate as an HMO in each of Texas, Florida, New Jersey, the District of Columbia and Illinois, and a MCO in Maryland. In each of the jurisdictions in which we operate, we are regulated by the relevant health, insurance and/or human services departments that oversee the activities of HMOs and MCOs providing or arranging to provide services to Medicaid enrollees.

      The process for obtaining the authorization to operate as an HMO or MCO is lengthy and complicated, and requires demonstration to the regulators of the adequacy of the health plan’s organizational structure, financial resources, utilization review, quality assurance programs and complaint procedures. Both under state HMO and MCO statutes and state insurance laws, our health plan subsidiaries must comply with minimum net worth requirements and other financial requirements, such as minimum capital, deposit and reserve requirements. Insurance regulations may also require the prior state approval of acquisitions of other managed care organizations’ businesses and the payment of dividends, as well as notice for loans or the transfer of funds. Each of our subsidiaries is also subject to periodic reporting requirements. In addition, each health plan must meet numerous criteria to secure the approval of state regulatory authorities before implementing operational changes, including the development of new product offerings and, in some states, the expansion of service areas.

14


Table of Contents

 
Medicaid

      Medicaid was established under the U.S. Social Security Act of 1965. It is a joint federal-state program in which each state:

  •  establishes its own eligibility standards,
 
  •  determines the type, amount, duration and scope of services,
 
  •  sets the rate of payment for services, and
 
  •  administers its own program.

      Medicaid policies for eligibility, services, rates and payment are complex, and vary considerably among states, and the state policies may change from time-to-time.

      States are also permitted by the federal government to seek waivers from requirements of the Social Security Act. The waivers most relevant to us are the Section 1915(b) freedom of choice waivers that enable:

  •  mandating Medicaid enrollment into managed care,
 
  •  utilizing a central broker for enrollment into plans,
 
  •  using cost savings to provide additional services, and
 
  •  limiting the number of providers for additional services.

      Waivers are approved for two-year periods and can be renewed on an ongoing basis if the state applies. A 1915(b) waiver cannot negatively impact beneficiary access or quality of care and must be cost-effective. Managed care initiatives may be state-wide and required for all classes of Medicaid eligible recipients, or may be limited to service areas and classes of recipients. All jurisdictions in which we operate, except Illinois, have some sort of mandatory Medicaid program. However, under the waivers pursuant to which the mandatory programs have been implemented, there must be at least two managed care plans operating from which Medicaid eligible recipients may choose.

      Many states, including Maryland, operate under a Section 1115 demonstration rather than a 1915(b) waiver. This is a more expansive form of waiver that enables the state to have a Medicaid program that is broader than typically permitted under the Social Security Act. For example, Maryland’s 1115 waiver allows it to include more individuals in its managed care program than typically allowed under Medicaid.

      In all the states in which we operate, we must enter into a contract with the state’s Medicaid regulator in order to be a Medicaid managed care organization. States generally use either a formal proposal process, reviewing many bidders, or award individual contracts to qualified applicants that apply for entry to the program. Although other states have done so in the past and may do so in the future, currently Texas, Florida and the District of Columbia are the only jurisdictions in which we operate that use competitive bidding processes.

      The contractual relationship with the state is generally for a period of one to two years and renewable on an annual or biannual basis. The contracts with the states and regulatory provisions applicable to us generally set forth in great detail the requirements for operating in the Medicaid sector including provisions relating to:

  •  eligibility, enrollment and disenrollment processes,
 
  •  covered services,
 
  •  eligible providers,
 
  •  subcontractors,
 
  •  record-keeping and record retention,
 
  •  periodic financial and informational reporting,
 
  •  quality assurance,

15


Table of Contents

  •  marketing,
 
  •  financial standards,
 
  •  timeliness of claims’ payment,
 
  •  health education and wellness and prevention programs,
 
  •  safeguarding of member information,
 
  •  fraud and abuse detection and reporting,
 
  •  grievance procedures, and
 
  •  organization and administrative systems.

      A health plan’s compliance with these requirements is subject to monitoring by the state regulator and by CMS. A health plan is subject to periodic comprehensive quality assurance evaluation by a third-party reviewing organization and generally by the insurance department of the jurisdiction that licenses the health plan. A health plan must also submit quarterly and annual statutory financial statements and utilization reports, as well as many other reports.

Federal Regulation

 
HIPAA

      In accordance with the Health Insurance Portability and Accountability Act of 1996, or HIPAA, health plans are required to comply with new regulations relating to standards for electronic transactions and code sets, privacy of health information, security of health care information, national provider identifiers, and national employer identifiers.

      In August 2000, the Department of Health and Human Services, or HHS, issued new standards for submitting electronic claims and other administrative health care transactions. These regulations are codified at 42 C.F.R. Part 162. Health care organizations that filed a written compliance plan by October 2002 were required to comply with the new standards as of October 16, 2003. The regulation’s requirements apply when a transaction is transmitted using “electronic media.” Health plans are required to have the capacity to accept and send all covered transactions in a standardized electronic format. In anticipation that the industry as a whole would not be prepared to achieve compliance with the regulatory requirements by October 16, 2003, and in furtherance of our best efforts to achieve compliance by the earliest possible date, we developed a contingency plan to achieve compliance in coordination with efforts undertaken by the state Medicaid agencies, our contracted clearinghouses and our providers.

      On July 24, 2003, CMS publicly released a document outlining its guidance on compliance with transactions and code sets after October 16, 2003. In the guidance, CMS stated that it will focus on obtaining voluntary compliance by using a complaint-driven process. If CMS received a complaint, CMS will evaluate the entity’s “good faith efforts” to comply with the standards. CMS has stated that it will not impose penalties on covered entities that deploy contingencies (in order to ensure the smooth flow of payments) if they have made reasonable and diligent efforts to become compliant and, in the case of health plans, to facilitate the compliance of their trading partners. In determining whether a good faith effort has been made, CMS will place a strong emphasis on sustained and demonstrable progress.

      On April 14, 2003, health plans and providers were required to be in compliance with HHS privacy regulations. The regulations are designed to protect member information, medical records and other personal health information kept and used by health care providers, hospitals, health plans and health insurers, and health care clearinghouses. We have implemented the programs and systems that were required for compliance with the new privacy regulations by the required deadline. To verify our compliance, we were audited by Utilization Review Accreditation Commission and obtained full accreditation for compliance with their privacy standards.

      On February 20, 2003, HHS published its final security regulations. The security rule applies only to protected health information in electronic form, and is specifically concerned with security information systems.

16


Table of Contents

While we fully expect to be compliant with the security rule by the April 2005 compliance date, we have not yet determined the specific acts, costs or risks involved in achieving such timely compliance.

      AMERIGROUP had expenses of approximately $2.6 million and $2.5 million on HIPAA compliance in 2003 and 2002, respectively. Additional costs may be incurred in 2004 in complying with the transaction standards and with the security regulations. We are in the process of interpreting the security regulations and cannot estimate the cost of compliance at this time. Further, compliance with these regulations requires changes to many of the procedures we previously used to conduct our business, which may lead to additional costs that we have not yet identified. We do not know whether, or the extent to which, we will be able to recover from the states our costs of complying with these new regulations.

 
New Medicaid Managed Care Regulations

      On January 19, 2001, HHS issued new Medicaid managed care regulations to implement certain provisions of the Balanced Budget Act of 1997, or BBA. These provisions permit states to require certain Medicaid beneficiaries to enroll in managed care programs, give states more flexibility to develop their managed care programs and provide certain new protections for Medicaid beneficiaries. States had until August 13, 2003 to bring their Medicaid managed care programs into compliance with the requirements of the rule.

      The rule implements BBA provisions intended to (i) give states the flexibility to enroll certain Medicaid recipients in managed care plans without a federal waiver if the state provides the recipients with a choice of managed care plans; (ii) establish protections for members in areas such as quality assurance, grievance rights and coverage of emergency services; and (iii) eliminate certain requirements viewed by the states as impediments to the growth of managed care programs, such as the enrollment composition requirement, the right to disenroll without cause at any time, and the prohibition against enrollee cost sharing. The rule also establishes strict requirements intended to ensure that state Medicaid managed care capitation rates are actuarially sound.

      According to HHS, this requirement eliminates the generally outdated regulatory ceiling on what states may pay managed care plans, a particularly important provision as more state Medicaid programs include people with chronic illnesses and disabilities in managed care.

      Although some of the states in which we operate have already implemented requirements similar to those provided for in the rule, the manner in which the rule is implemented in each of the states could increase our health care costs and administrative expenses, reduce our reimbursement rates, and otherwise adversely affect our business, results of operations, and financial condition.

 
Medicaid Reform

      As part of the current Administration’s 2004 Budget submission to Congress in January 2003, HHS announced principles for Medicaid reform. HHS’s proposal would have established two capped allotments for the states combining both Medicaid and SCHIP funds, one for acute care and one for long term care. Under this proposal, all mandatory populations and benefits would continue to be covered as required under current law. States, however, would be given flexibility for optional populations and benefits. The proposal would be revenue-neutral over a ten-year period, although states would receive an additional $13.0 billion over the first seven years, with corresponding funding reductions in years eight through ten.

      The proposal was meant to provide increased flexibility to the states in managing their Medicaid and SCHIP programs, in particular in the design of benefit packages for optional populations. Governors working in concert with HHS were unable to reach agreement on these principles and the proposal has been currently set aside. In the President’s Budget that was released on February 2, 2004, the Administration did not include the Medicaid reform proposal that it had submitted the previous year due to the concerns of the governors. Rather, the Administration stated in the budget document it would work individually with states and continue to look for new and innovative ways to address the challenges facing Medicaid. The budget document states that the Administration hopes in the future it will be able to pass legislation similar to its proposal from last year. It is uncertain whether this proposal from last year, or a variation thereof, will be enacted sometime in the future.

17


Table of Contents

 
Patients’ Rights Legislation

      The United States Congress has considered several versions of patients’ rights legislation in previous sessions. Though no bill has been introduced in the 108th Congress, it is likely to remain an issue. Legislation could expand our potential exposure to lawsuits and increase our regulatory compliance costs. Depending on the final form of any patients’ rights legislation, such legislation could, among other things, expose us to liability for economic and punitive damages for making determinations that deny benefits or delay beneficiaries’ receipt of benefits as a result of our medical necessity or other coverage determinations. There are significant differences between the Senate, House of Representatives and the current Administration’s positions, which could again delay any final bill. We cannot predict whether patients’ rights legislation will be enacted into law or, if enacted, what final form such legislation might take.

 
Other Fraud and Abuse Laws

      Investigating and prosecuting health care fraud and abuse has become a top priority for law enforcement entities. The funding of such law enforcement efforts has increased in the past few years and these increases are expected to continue. The focus of these efforts has been directed at participants in public government health care programs such as Medicaid. These regulations and contractual requirements applicable to participants in these programs are complex and changing. We have re-emphasized our regulatory compliance efforts for these programs, but ongoing vigorous law enforcement and the highly technical regulatory scheme mean that compliance efforts in this area will continue to require substantial resources.

Customers

      As of December 31, 2003, we served members who received health care benefits through our 13 contracts with the regulatory entities in the jurisdictions in which we operate. Five of these contracts, which are with the States of Texas, Florida, Maryland and New Jersey, individually accounted for 10% or more of our revenues for the year ended December 31, 2003, with the largest of these contracts representing approximately 20% of our revenues.

Employees

      As of December 31, 2003, we had approximately 2,100 employees. Our employees are not represented by a union. We believe our relationships with our employees are good.

Available Information

      We file annual, quarterly and current reports, proxy statements and all amendments to these reports and other information with the United States Securities and Exchange Commission, or SEC. We make available free of charge on or through our website at www.amerigroupcorp.com our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and all amendments to those reports as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC. Further, we will provide, without charge upon written request, a copy of our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and all amendments to those reports. Requests for copies should be addressed to Investor Relations, AMERIGROUP Corporation, 4425 Corporation Lane, Virginia Beach, VA 23462.

 
Item 2. Properties

      We do not own any real property. We lease office space in Virginia Beach, Virginia, where our headquarters, call, claims and data centers are located. We also lease real property in each of the health plan locations. We are obligated by various insurance and Medicaid regulatory authorities to have offices in the service areas where we provide Medicaid benefits.

      The lease for our Virginia Beach call and data centers facility terminates in September 2004. We entered into a 15-year lease, dated as of September 15, 2003, for a new 106,000 square-foot building in Virginia Beach,

18


Table of Contents

Virginia, construction for which is scheduled to be completed in September 2004. At this facility we will locate our Virginia Beach call center, our primary data center and other support functions.
 
Item 3. Legal Proceedings

      On July 18, 2002, Texas Children’s Hospital, or TCH, in Houston filed suit in State District Court against AMERIGROUP Texas, Inc., our Texas subsidiary, seeking to be paid full-billed charges for all services rendered to our Texas subsidiary’s Medicaid members since October 1999. Our Texas subsidiary does not have a contract with TCH to provide services to its Medicaid members. When TCH provides services to our members, it does so as a non-network provider. On January 17, 2003, the physicians of Baylor College of Medicine, or Baylor, non-network providers who provide medical services at TCH, filed suit against our Texas subsidiary seeking full-billed charges for services provided since October 1999 to our Texas Medicaid members. On July 7, 2003, TCH and Baylor added AMERIGROUP Corporation as an additional defendant to the lawsuits, alleging that we are directly liable for the obligations of our Texas subsidiary.

      Our Texas subsidiary’s contracts with the State of Texas provide a methodology for compensating non-network providers for services provided to our Medicaid members and the State of Texas has approved our Texas subsidiary’s current non-network provider payment methodology. TCH and Baylor each assert that they are not a party to the contract our Texas subsidiary has with the State of Texas and, therefore, they are not obligated to accept the payments determined in accordance with our State contract. The State approved our subsidiary’s payment methodology for the period prior to January 1, 2003 and determined that it was appropriate with respect to compensating non-network providers other than TCH and Baylor. Therefore, we believe that our payment methodology approved by the State should be equally applicable to TCH and Baylor. We believe that our methodology for calculating payments to TCH and Baylor as non-network providers is appropriate and we will vigorously defend against the claims of TCH and Baylor. If we are required to pay full-billed charges to TCH and Baylor at the conclusion of litigation and all appeals, it could have a material adverse effect on us.

      On July 21, 2003, we filed a motion with the Court to abate the suit and have the issues resolved through an administrative procedure by the Texas Health and Human Services Commission, or HHSC, which we believe has exclusive jurisdiction to resolve out-of-network provider complaints concerning reimbursements by Medicaid managed care organizations.

      On November 10, 2003, the Court granted our Motion to Abate the claims of TCH and Baylor and further ordered that there be no further discovery or other action by the parties on these claims until TCH and Baylor have completed the administrative process with HHSC. To our knowledge TCH has not initiated an administrative complaint in accordance with the court’s order. However, in March 2004 we received notice from HHSC that it had commenced a review of certain claims payment issues raised by TCH in early 2002, which are part of the subject matter of the lawsuit.

      TCH and Baylor requested an early review of the Court’s decision by the Court of Appeals in a Writ of Mandamus action. The Court has not rendered a decision in this mandamus action.

      In May 2002, Capital Health Systems, or Capital, in New Jersey filed an action against our New Jersey subsidiary, in the Superior Court of New Jersey, Mercer County Law Division, seeking to be paid full-billed charges for all services rendered to our New Jersey subsidiary’s Medicaid members since January 1, 2002. Our New Jersey subsidiary has not had a contract with Capital to provide services to its Medicaid members since December 31, 2001. As a result, services provided by Capital to our members since January 1, 2002 have been provided as a non-network provider. Capital asserts that our New Jersey subsidiary agreed to pay full-billed charges upon the expiration of our contract with them on December 31, 2001. The Court ruled in favor of Capital on August 8, 2003, and determined that our New Jersey subsidiary entered into a new contract with Capital as of December 31, 2001. Capital filed a notice of motion for summary judgment on damages on September 12, 2003, seeking approximately $8.5 million. Capital’s motion was denied on December 5, 2003. We have petitioned the Appeals Court for leave to file an interlocutory appeal of the Court’s summary judgment on the issue of liability. The petition is currently pending before the appellate division. On February 20, 2004, the court adjourned the March 1, 2004 trial on the issue of damages.

19


Table of Contents

      We disagree with the Court’s ruling and believe that we have provided payment to Capital in an appropriate manner. Once a determination of damages is made, we intend to appeal the ruling. Our payments to Capital in their role as a non-network provider were based upon our understanding of the usual and customary reimbursement practices in New Jersey. Effective July 1, 2003, New Jersey mandated that payments to non-network facilities for emergency services be limited to the State’s Medicaid fee-for-service rates. If we are required to pay full-billed charges to Capital at the conclusion of all appeals, it could have a material adverse effect on us.

      We are from time-to-time the subject matter of, or involved in, other legal proceedings including claims for reimbursement by providers. We believe that any liability or loss resulting from such matters will not have a material adverse effect on our financial position or results of operations.

 
Item 4. Submission of Matters to a Vote of Security Holders

      None.

Executive Officers of the Company

      Our executive officers, their ages and positions as of February 29, 2004, are as follows:

             
Name Age Position



Jeffrey L. McWaters
    47     Chairman of the Board of Directors and Chief Executive Officer
James G. Carlson
    51     President, Chief Operating Officer
Lorenzo Childress, Jr., M.D. 
    57     Executive Vice President, Chief Medical Officer
Stanley F. Baldwin
    55     Executive Vice President, General Counsel and Secretary
James E. Hargroves
    61     Executive Vice President, Corporate Development
Catherine S. Callahan
    46     Executive Vice President, Administrative Services
Nancy L. Grden
    52     Executive Vice President, Planning and Development
Leon A. Root, Jr. 
    50     Executive Vice President, Chief Information Officer
Kathleen K. Toth
    42     Executive Vice President, Chief Accounting Officer
John E. Littel
    39     Senior Vice President, Government Relations
Sherri E. Lee
    52     Senior Vice President, Treasurer
Richard C. Zoretic
    45     Senior Vice President, Chief Marketing Officer

      Jeffrey L. McWaters has been our Chairman of the Board of Directors and Chief Executive Officer since he founded our company in December 1994. From 1991 to 1994, Mr. McWaters served as President and Chief Executive Officer of Options Mental Health, a national managed behavioral health care company and prior to that, in various senior operating positions with EQUICOR-Equitable HCA Corporation and CIGNA HealthCare. Mr. McWaters is Vice Rector of the Board of Visitors of the College of William and Mary, a director of the American Association of Health Plans and a member of the New York Stock Exchange Listed Companies Advisory Board.

      James G. Carlson joined us as our President and Chief Operating Officer in April 2003. Prior to joining us, Mr. Carlson co-founded Workscape, Inc. in 1999, a privately held provider of benefits and workforce management solutions, for which he also served as Chief Executive Officer and a Director. From 1995 to 1998, Mr. Carlson served as Executive Vice President of UnitedHealth Group and President of the UnitedHealthcare business unit, which served more than 10 million members in HMO and PPO plans nationwide.

      Lorenzo Childress, Jr., M.D. has served as our Chief Medical Officer since 1995. From 1992 to 1995, Dr. Childress was the Chief Operating Officer and Medical Director of Metro Medical Group, an indirect wholly owned subsidiary of the Henry Ford Health System.

      Stanley F. Baldwin has served as our General Counsel and Secretary since 1997. Prior to that, Mr. Baldwin held senior officer and General Counsel positions with EPIC Healthcare Group, Inc., EQUICOR-Equitable HCA

20


Table of Contents

Corporation and CIGNA Healthplans, Inc. Mr. Baldwin is a member of the Bar of Tennessee and the Bar of Texas.

      James E. Hargroves has served as our head of Corporate Development since joining us in 1996. From 1994 to 1996, Mr. Hargroves was the President, founder and principal of Waterline Advisory Group, Inc., a corporate intermediary firm that provided merger and acquisition advisory services to health-related businesses, insurers, physicians and others.

      Catherine S. Callahan joined us in 1999 and serves as our head of Associate Services. From 1991 to 1999, Ms. Callahan was Chief Administrative Officer of FHC Health System.

      Nancy L. Grden joined us as our head of Planning and Development in 2001. Prior to joining us, Ms. Grden served as President and Founder of Avenir, LLC, a consulting firm specializing in new ventures, and as Chief Executive Officer for Lifescape, LLC, a web-based workplace services company, from 1998 to 2000. She previously served as Executive Vice President and Chief Marketing Officer for ValueOptions, a national managed behavioral health care company, from 1992 to 1998.

      Leon A. Root, Jr. joined us in May 2002 as a Senior Vice President and has served as our Chief Information Officer since June 2003. From 2001 to 2002, Mr. Root served as Senior Vice President and Chief Information Officer at Medunite, Inc., a private e-commerce company. From 1998 to 2001, Mr. Root served as Senior Vice President of McKessonHBOC Business System Division.

      Kathleen K. Toth joined us in 1995 and serves as our Chief Accounting Officer. Prior to joining us, Ms. Toth was the Vice President of Service Operations at Options Mental Health from 1992 to 1995. Ms. Toth also worked for CIGNA Healthplan of Texas, Inc. as Director of Financial Services and for EQUICOR Health Plan of Florida as Controller from 1987 to 1992. Ms. Toth is a certified public accountant.

      John E. Littel joined us in 2001 as head of Government Relations. Mr. Littel has served in a variety of positions in federal and state governments, including as Deputy Secretary of Health and Human Resources for the Commonwealth of Virginia, where he was responsible for the state’s welfare reform and health care initiatives. Mr. Littel is a member of the Bar of Pennsylvania.

      Sherri E. Lee joined us in 1998 as our Chief Financial Officer and Treasurer. In 2001, Ms. Lee resigned her position as Chief Financial Officer, but continues to serve as Treasurer. Ms. Lee served as Executive Vice President — Finance of Pharmacy Corporation of America and prior to that, as Senior Vice President and Controller for Beverly Enterprises, Inc. Ms. Lee is a certified public accountant.

      Richard C. Zoretic was named as our Chief Marketing Officer on September 23, 2003. Before joining us, Mr. Zoretic served as Senior Vice President of network operations and distribution at CIGNA Dental Health since February 2003. From November 2001 to February 2003, Mr. Zoretic worked as a senior manager for Deloitte Consulting’s global management consulting practice, specializing in the health plan segment. From March 2000 to October 2001, Mr. Zoretic was an Executive Vice President and General Manager of Workscape, Inc., a privately held provider of benefits and workforce management solutions. From October 1995 to March 2000, Mr. Zoretic served in a variety of leadership positions at United Healthcare Group, including President of United Healthcare’s Middle Market Business segment and Regional Operating President of United Healthcare’s Mid-Atlantic operations, including its Maryland plan, for which he also served as Chief Executive Officer.

21


Table of Contents

PART II.

 
Item 5. Market for Our Common Equity and Related Stockholder Matters

      Our common stock has been listed on the New York Stock Exchange under the symbol “AGP” since January 3, 2003. From November 6, 2001 until January 2, 2003, our common stock was quoted on the NASDAQ National Market. Prior to November 6, 2001, there was no public market for our common stock.

      The following table sets forth, for the periods indicated, the range of high and low sales price for our common stock for the periods indicated.

                 
2002 High Low



First Quarter
  $ 30.19     $ 20.65  
Second Quarter
    35.49       20.25  
Third Quarter
    34.29       21.72  
Fourth Quarter
    35.38       25.90  
                 
2003

First Quarter
    33.76       24.00  
Second Quarter
    38.60       27.26  
Third Quarter
    45.71       36.70  
Fourth Quarter
    47.64       39.60  
December 31, 2003 Closing Sales Price
  $ 42.65          

      On March 2, 2004, the last reported sales price of the Common Stock was $42.72 per share as reported on the New York Stock Exchange. As of March 2, 2004, we had 42 shareholders of record.

      We have never declared or paid any cash dividends on our common stock. We currently anticipate that we will retain any future earnings for the development and operation of our business. Also, as long as our credit facility is outstanding, we are not able to pay dividends to our stockholders without the consent of our lenders. Accordingly, we do not anticipate declaring or paying any cash dividends in the foreseeable future.

      In addition, our ability to pay dividends is dependent on cash dividends from our subsidiaries. State insurance and Medicaid regulations limit the ability of our subsidiaries to pay dividends to us.

Use of Proceeds from Public Offering

      On October 16, 2003, we completed a public offering of 3,162,500 shares of common stock, including an over-allotment issuance of 412,500 shares. The shares of common stock sold in the offering were registered under the Securities Act of 1933, as amended, on a Registration Statement on Form S-3, Registration Number 333-108831, which was declared effective by the Securities and Exchange Commission on October 9, 2003, and a Registration Statement on Form S-3, Registration Number 333-109609, filed with the Securities and Exchange Commission pursuant to Rule 462(b) of the General Rules and Regulations under the Securities Act of 1933, as amended, on October 9, 2003. All 3,162,500 shares sold in the public offering were sold at a price of $46.50 per share for an aggregate offering price of $147.1 million. We received proceeds from the offering of approximately $138.8 million, net of approximately $7.4 million of underwriting fees and $0.9 million of expenses. On October 21, 2003, we used $30.0 million of proceeds from the offering to repay the outstanding balance of our then-existing credit facility. The balance of approximately $108.8 million will be used for general corporate purposes, including acquisitions of businesses, asset and technologies.

      Banc of America Securities LLC and Credit Suisse First Boston LLC acted as joint book-running managers of the offering. CIBC World Markets Corp. and Stephens Inc. acted as representatives of the underwriters.

22


Table of Contents

Forward-looking Statements

      This Annual Report on Form 10-K, and other information we provide from time-to-time, contains certain “forward-looking” statements as that term is defined by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, membership, results of operations or cash flows, our continued performance improvements, our ability to service our debt obligations and refinance our debt obligations, our ability to finance growth opportunities, our ability to respond to changes in government regulations and similar statements including, without limitation, those containing words such as “believes,” “anticipates,” “expects,” “may,” “will,” “should,” “estimates,” “intends,” “plans,” and other similar expressions are forward-looking statements.

      Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements as a result of, but not limited to, the following factors:

  •  national, state and local economic conditions, including their effect on the rate increase process, timing of payments, as well as their effect on the availability and cost of labor, utilities and materials,
 
  •  the effect of government regulations and changes in regulations governing the health care industry, including our compliance with such regulations and their effect on certain of our unit cost and our ability to manage our medical costs,
 
  •  changes in Medicaid payment levels and methodologies and the application of such methodologies by the government,
 
  •  liabilities and other claims asserted against the company,
 
  •  our ability to attract and retain qualified personnel,
 
  •  our ability to maintain compliance with all minimum capital requirements,
 
  •  the availability and terms of capital to fund acquisitions and capital improvements,
 
  •  the competitive environment in which we operate,
 
  •  our ability to maintain and increase membership levels, and
 
  •  demographic changes.

      Investors should also refer to the section entitled “Risk Factors” following section 7A entitled “Quantitative and Qualitative Disclosures About Market Risk” for a discussion of risk factors. Given these risks and uncertainties, we can give no assurances that any forward-looking statements will, in fact, transpire and, therefore, caution investors not to place undue reliance on them.

 
Item 6. Selected Financial Data

      The following selected consolidated financial data should be read in connection with the financial statements and related notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations appearing elsewhere in this Form 10-K. Selected financial data as of and for each of the years in the five-year

23


Table of Contents

period ended December 31, 2003 are derived from our consolidated financial statements, which have been audited by KPMG LLP, independent certified public accountants.
                                             
Year ended December 31,

2003 2002 2001 2000 1999





(Dollars in thousands, except per share data)
Income Statement Data:
                                       
Revenues:
                                       
 
Premium
  $ 1,615,508     $ 1,152,636     $ 880,510     $ 646,408     $ 392,296  
 
Investment income
    6,726       8,026       10,664       13,107       6,404  
     
     
     
     
     
 
   
Total revenues
    1,622,234       1,160,662       891,174       659,515       398,700  
     
     
     
     
     
 
Expenses:
                                       
 
Health benefits
    1,295,900       933,591       709,034       523,566       334,192  
 
Selling, general and administrative
    186,856       133,409       109,822       85,114       52,846  
 
Depreciation and amortization
    23,650       13,149       9,348       6,275       3,635  
 
Interest
    1,913       791       763       781       811  
     
     
     
     
     
 
   
Total expenses
    1,508,319       1,080,940       828,967       615,736       391,484  
     
     
     
     
     
 
   
Income before income taxes
    113,915       79,722       62,207       43,779       7,216  
Income tax (expense) benefit
    (46,591 )     (32,686 )     (26,127 )     (17,687 )     4,100  
     
     
     
     
     
 
   
Net income
    67,324       47,036       36,080       26,092       11,316  
Accretion of redeemable preferred stock dividends
                (6,228 )     (7,284 )     (7,284 )
     
     
     
     
     
 
   
Net income attributable to common stockholders
  $ 67,324     $ 47,036     $ 29,852     $ 18,808     $ 4,032  
     
     
     
     
     
 
Basic net income per share
  $ 3.11     $ 2.33     $ 8.08     $ 23.62     $ 7.11  
     
     
     
     
     
 
Weighted average number of shares outstanding
    21,622,704       20,177,728       3,694,844       796,409       567,146  
     
     
     
     
     
 
Diluted net income per share
  $ 2.95     $ 2.19     $ 2.08     $ 1.55     $ 0.66  
     
     
     
     
     
 
Weighted average number of shares and dilutive potential common shares outstanding
    22,801,650       21,469,422       16,649,721       15,818,175       14,695,324  
     
     
     
     
     
 
                                           
December 31,

2003 2002 2001 2000 1999





(Dollars in thousands)
Balance Sheet Data:
                                       
 
Cash and cash equivalents and short and long-term investments
  $ 535,103     $ 306,935     $ 301,837     $ 189,325     $ 166,218  
 
Total assets
    826,021       578,484       406,942       268,126       222,321  
 
Long-term debt (including current portion and capital leases)
    10,518       59,443       4,188       6,594       8,010  
 
Total liabilities
    364,307       339,103       223,426       185,191       166,426  
 
Redeemable preferred stock
                      78,190       70,906  
 
Stockholders’ equity (deficit)
    461,714       239,381       183,516       4,745       (15,011 )

24


Table of Contents

 
Item 7. Management’s Discussion and Analysis of Results of Operations and Financial Condition

Overview

      We are a multi-state managed health care company focused on serving people who receive health care benefits through publicly sponsored programs, including Medicaid, SCHIP and FamilyCare. We were founded in December 1994 with the objective to become the leading managed care organization in the United States focused on serving people who receive these types of benefits. Calendar year 2003 was our second full-year as a public company and our first year trading on the New York Stock Exchange.

      In 2003 we increased our total revenues by 39.8% over 2002. Our 2003 revenue growth came from a number of factors including:

  •  External growth through acquisitions:

  •  Effective January 1, 2003, we acquired the outstanding stock of PHP Holdings, Inc. and its subsidiary, Physicians Healthcare Plans, Inc. (together, PHP). With the acquisition of PHP, we began providing our products to approximately 193,000 additional members located in three Florida markets: Tampa, Orlando and Fort Lauderdale/ Miami.
 
  •  Effective July 1, 2003, we acquired the Medicaid contract rights and related assets of St. Augustine which operates in nine counties in the Miami/ Fort Lauderdale, Orlando and Tampa markets and served approximately 26,000 members.

  •  Obtaining rate increases from the states in which we operate — In a difficult state budgetary environment, we leveraged our partnerships with our states and received rate increases.
 
  •  Successfully integrating members we received from a competitor exiting a market — During the third quarter of 2003, we successfully integrated approximately 28,000 members in Texas which came to us from a competitor exiting that market.
 
  •  Implementing new product or program expansions:

  •  We expanded into two new counties in Florida.
 
  •  We successfully insourced our behavioral health benefits servicing approximately 463,000 members in four states and the District of Columbia. We believe this strategy optimizes member health status, and reinforces our mission to coordinate our members physical and behavioral health and positions us well for future growth in existing states.

  •  Expanding in existing service areas — Our 2003 same-store premium revenues increased 11.5% over 2002.

      Recent developments:

  •  The State of Florida oversubscribed its SCHIP or Florida Healthy Kids program and thus faced a state funding shortfall. The initial response from the State was to create a temporary waiting list. Florida recently announced a plan to possibly fund up to 90,000 additional SCHIP members.
 
  •  The State of Texas has announced its intent to award AMERIGROUP a contract for the Travis Service Area, which includes Austin and 7 additional counties, bringing the number of counties that we serve in the State to 27. We are currently finalizing the terms with the State and expect operations to begin in summer 2004. While initial estimates of growth are modest, this service area complements our long-term growth strategy. Currently, these counties are served by only one other health plan.

      In 2003, our health benefits ratio was 80.2% versus 81.0% in the 2002. Through effective early case finding, disease management, reductions in membership related to less profitable products and continued improvement in our claims payment efficiencies, our medical costs remain stable and predictable.

      Technological improvements during the last year helped us to maintain our SG&A ratio consistent with the prior year at 11.5%. An example of our technological improvements is the 52% increase in usage of our

25


Table of Contents

Interactive Voice Response system, which handled 1.3 million calls in 2003 without the interaction of a live representative agent. Over the last several years, our efforts to leverage our expenses have proven successful, resulting in a decreasing SG&A ratio.

      Cash and investments totaled $535.1 million at the end of 2003. A portion of this cash is regulated by state capital requirements. However, $199.9 million of our cash and investments was unregulated and held at the parent level.

      We expect acquisitions to continue to be an important part of our growth strategy. Over 45% of our membership has resulted from nine acquisitions and we are currently evaluating potential acquisition opportunities. We believe the proceeds from our recent public offering, our undrawn credit facility and our cash flows from operating activities position us to take advantage of acquisition opportunities.

Discussion of Critical Accounting Policies

      In the ordinary course of business, we have made a number of estimates and assumptions relating to the reporting of results of operations and financial condition in the preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ from those estimates and the differences could be significant. We believe that the following discussion addresses our critical accounting policies, which are those that are most important to the portrayal of our financial condition and results of operations and require management’s most difficult, subjective and complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.

 
Revenue recognition

      We generate revenues primarily from premiums we receive from the states in which we operate to arrange for health benefit services for our members. We generally receive premiums in advance of arranging for services, and recognize premium revenue during the period in which we are obligated to provide services to our members. A fixed premium per member per month is paid to us to arrange for health care benefit services for our members pursuant to our contracts in each of our markets. In all of our states except Florida, we receive supplemental payments for obstetric delivery. Upon delivery of a newborn, each state is notified according to our contract. We recognize revenue in the period that the newborn is delivered and related services were provided to our member. Additionally, in some states we receive supplemental payments for certain services such as high cost drugs and early childhood prevention screenings. Any amounts that have not been received from the state by the end of the period are recorded on our balance sheet as premium receivables. We also generate income from investments.

 
Estimating health benefits expense and claims payable

      Our results of operations depend on our ability to effectively manage expenses related to health benefits, as well as our ability to accurately predict costs incurred in recording the amounts in our consolidated financial statements. Expenses related to health benefits have two components: direct medical expenses and medically related administrative costs. Direct medical expenses include fees paid to hospitals, physicians and providers of ancillary medical services, such as pharmacy, laboratory, radiology, dental and vision. Medically related administrative costs include expenses related to services such as health promotion, quality assurance, case management, disease management and 24-hour on-call nurses. Direct medical expenses also include estimates of medical expenses incurred but not yet reported, or IBNR. For the year ended December 31, 2003, approximately 93% of our direct medical payments related to fees paid on a fee-for-service basis to our PCPs, specialist physicians and other providers, including fees paid to third-party vendors for ancillary services. The balance related to fees paid on a capitation, or per member, basis. Primary care and specialist physicians not paid on a capitated basis are paid on a maximum allowable fee schedule set forth in the contracts with our providers. We reimburse hospitals on a negotiated per diem, case rate or an agreed upon percent of their standard charges. In Maryland, the state sets the amount reimbursed to hospitals.

26


Table of Contents

      We have used the same methodology for estimating our medical expenses and medical liabilities since our inception, and have refined our assumptions to take into account our maturing claims and market experience. As medical utilization patterns and cost trends change from year-to-year, our underlying claims payments reflect the variations in experience. Our estimates are revised based upon actual claims payments using historical per-member, per-month claims cost, including provider settlements, changes in the age and gender of our membership and variations in the severity of medical conditions. These variations are considered in determining our current medical liabilities and adjusted to reflect expected changes in cost or utilization patterns.

      There are certain aspects of the managed care business that are not predictable with consistency. These aspects include the incidences of illness or disease state (e.g., cardiac heart failure cases, cases of upper respiratory illness, diabetes, the number of full-term versus premature births, and the number of neonatal intensive care babies) as well as non-medical aspects, such as changes in provider contracting and contractual benefits. Therefore, we must rely upon our historical experience, as continually monitored, to reflect the ever-changing mix and growth of members.

      Monthly, we estimate our IBNR based on a number of factors, including authorization data and prior claims experience. Authorization data is information captured in our medical management system, which identifies services requested by providers or members. The medical cost related to these authorizations is estimated by pricing the approved services using contractual or historical amounts adjusted for known variables such as historical claims trends. These estimated costs are included as a component of IBNR. As part of this review, we also consider the costs to process medical claims, and estimates of amounts to cover uncertainties related to fluctuations in claims payment patterns, membership, products and authorization trends. These estimates are adjusted as more information becomes available and any adjustments are included in current operations. We utilize the services of independent actuarial consultants, who are contracted to review our estimates quarterly. Judgments are made based on knowledge and experience about past and current events. There is a likelihood that actual results could be materially different if different assumptions or conditions prevail.

      Also included in claims payable are estimates for provider settlements due to clarification of contract terms, out-of-network reimbursement and claims payment differences, as well as amounts due to or from contracted providers under risk-sharing arrangements.

      The following table shows the components of the change in medical claims payable for the years ended December 31, 2003, 2002 and 2001 (in thousands):

                             
2003 2002 2001



Medical claims payable as of January 1
    $202,430       $180,346       $150,462  
Medical claims payable assumed from businesses acquired during the year
    20,421              
Health benefits expenses incurred during the year:
                       
 
Related to current year
    1,355,065       988,628       768,519  
 
Related to prior years
    (59,165 )     (55,037 )     (59,485 )
     
     
     
 
   
Total incurred
    1,295,900       933,591       709,034  
Health benefits payments during the year:
                       
 
Related to current year
    1,135,082       803,432       597,332  
 
Related to prior years
    144,137       108,075       81,818  
     
     
     
 
   
Total payments
    1,279,219       911,507       679,150  
     
     
     
 
Medical claims payable as of December 31
    $239,532       $202,430       $180,346  
     
     
     
 

      Changes in estimates of incurred claims for prior years recognized during 2003, 2002 and 2001 were attributable to lower than anticipated utilization and pricing of medical services.

      Due to the variable nature of claims, our methodology includes adding a factor to compensate for uncertainty. The more precisely we have been able to predict claims patterns, the lower the required factor for

27


Table of Contents

uncertainty. The health benefits expenses incurred during the period related to prior years relate almost entirely to revisions in estimates for the immediately preceding year. The application of our methodology, even in a changing environment, has resulted in reversals of estimated incurred claims related to the prior year in each of the years in the three year period ended December 31, 2003. The resulting impact on operations is a function of the variation of the change in estimate from year-to-year. In certain circumstances we adjust claims for overpayments. A portion of these adjustments may not be collected, so we estimate a historical factor to offset the expected recoupment.

      Changes in estimates are primarily the result of obtaining more complete claims information that directly correlates with the claims and provider reimbursement trends. Since our estimates are based upon the blended per-member, per-month claims experience, changes cannot typically be explained by any single factor, but are the result of a number of interrelated variables, all influencing the resulting experience. These variables include fluctuations in claims payment patterns, changes in membership levels, number and mix of products, benefit structure, severity of illness and authorization trends. We believe there will be less volatility as we increase in size and gain more maturity in our markets.

      We believe that the amount of claims payable is adequate to cover our ultimate liability for unpaid claims as of December 31, 2003; however, actual claim payments and other items may differ from established estimates. Assuming a hypothetical 1% difference between our December 31, 2003 estimates of claims payable and actual claims payable, net income for the year ended December 31, 2003 would increase or decrease by approximately $1.4 million and diluted earnings per share would increase or decrease by approximately $0.06 per share.

 
Income taxes

      On a quarterly basis, we estimate our required tax liability and assess the recoverability of our deferred tax assets. Our taxes payable are estimated based on enacted rates, including estimated tax rates in states where we do business applied to the income expected to be taxed currently. Management assesses the realizability of our deferred tax assets based on the availability of carrybacks of future deductible amounts and management’s projections for future taxable income. We cannot guarantee that we will generate income in future years. Historically we have not experienced significant differences in our estimates of our tax accrual.

 
Goodwill and intangible assets

      As of December 31, 2003 and 2002, we had goodwill and other intangible assets of $144.4 million and $26.0 million, respectively, net of accumulated amortization. We review our intangible assets with defined lives for impairment whenever events or changes in circumstances indicate we might not recover their carrying value. We assess our goodwill for impairment at least annually. In assessing the recoverability of these assets, we must make assumptions regarding estimated future utility and cash flows and other internal and external factors to determine the fair value of the respective assets. If these estimates or their related assumptions change in the future, we may be required to record impairment charges for these assets.

Results of Operations

      The following table sets forth selected operating ratios for the years ended December 31, 2003, 2002 and 2001. All ratios, with the exception of the health benefits ratio, are shown as a percentage of total revenues.

                         
2003 2002 2001



Premium revenue
    99.6 %     99.3 %     98.8 %
Investment income
    0.4       0.7       1.2  
     
     
     
 
Total revenues
    100.0 %     100.0 %     100.0 %
     
     
     
 
Health benefits(1)
    80.2 %     81.0 %     80.5 %
Selling, general and administrative expenses
    11.5 %     11.5 %     12.3 %
Income before income taxes
    7.0 %     6.9 %     7.0 %
Net income
    4.2 %     4.1 %     4.0 %


(1)  The health benefits ratio is shown as a percentage of premium revenue because there is a direct relationship between the premium received and the health benefits provided.

28


Table of Contents

      The following table sets forth the approximate number of our members in each of our service areas for the periods presented.

                                         
December 31,

Market 2003 2002 2001 2000 1999






Houston
    144,000       139,000       100,000       57,000       40,000  
Dallas
    93,000       84,000       64,000       42,000       34,000  
Fort Worth
    106,000       73,000       50,000       40,000       33,000  
New Jersey
    99,000       99,000       88,000       57,000       46,000  
Maryland
    124,000       125,000       118,000       95,000       83,000  
District of Columbia
    38,000       37,000       13,000       13,000       12,000  
Chicago
    32,000       34,000       39,000       29,000       20,000  
Tampa
    132,000                          
Orlando
    42,000                          
Miami/ Ft. Lauderdale
    47,000                          
     
     
     
     
     
 
Total
    857,000       591,000       472,000       333,000       268,000  
     
     
     
     
     
 

Year Ended December 31, 2003 Compared to Year Ended December 31, 2002

 
Revenues

      Premium revenue for the year ended December 31, 2003 increased $462.9 million, or 40.2%, from $1,152.6 million in 2002. The increase was primarily due to the acquisition of PHP (193,000 members) and St. Augustine (26,000 members) as well as internal growth in overall membership. Total membership increased 45.0% to 857,000 as of December 31, 2003 from 591,000 as of December 31, 2002.

      Investment income decreased $1.3 million to $6.7 million for the year ended December 31, 2003. The decrease in investment income is primarily due to the continued decline in market interest rates and increased levels of tax-advantaged securities partially offset by an increase in overall cash and investments levels throughout the year. Cash and investments levels have increased due to proceeds from our public offering and cash generated from operations.

 
Health benefits

      Expenses relating to health benefits for the year ended December 31, 2003 increased $362.3 million, or 38.8%, to $1,295.9 million from $933.6 million for the year ended December 31, 2002. The increase was primarily due to the increase in membership. The health benefits ratio, as a percentage of premium revenue, for the year ended December 31, 2003 was 80.2% compared to 81.0% in 2002.

 
Selling, general and administrative expenses

      Selling, general and administrative expenses increased $53.5 million to $186.9 million for the year ended December 31, 2003 compared to $133.4 million in 2002. The increase in selling, general and administrative expenses was primarily due to an increase in wages and related expenses for additional staff to support our increased membership, expenses related to implementation of the HIPAA guidelines, as well as expenses related to market development activities. Our selling, general and administrative expense ratio to revenue was 11.5% for both the years ended December 31, 2003 and 2002.

 
Interest expense

      Interest expense was $1.9 million and $0.8 million for the years ended December 31, 2003 and 2002, respectively. The increase primarily relates to increased average borrowings under our revolving credit facility to partially finance the PHP acquisition. On October 21, 2003, we used a portion of the net proceeds from our October 16, 2003 public offering to repay the outstanding balance under our revolving credit facility.

29


Table of Contents

 
Provision for income taxes

      Income tax expense for 2003 was $46.6 million with an effective tax rate of 40.9% as compared to the $32.7 million for 2002 with an effective tax rate of 41.0%.

 
Net income

      Net income for 2003 rose $20.3 million to $67.3 million, or $2.95 per diluted share, compared to $47.0 million, or $2.19 per diluted share in 2002. Diluted earnings per share rose 34.7% as compared to an increase in net income of 43.2%, due to the increase in shares outstanding primarily resulting from the issuance of 3,162,500 shares from our October 16, 2003 public offering.

Year Ended December 31, 2002 Compared to Year Ended December 31, 2001

 
Revenues

      Premium revenue for the year ended December 31, 2002 increased $272.1 million, or 30.9%, to $1,152.6 million from $880.5 million for the year ended December 31, 2001. The increase was principally due to internal growth in overall membership and, to a lesser extent, the acquisition of the Medicaid contracts and related assets of Humana’s Houston, Texas business in August 2001 (15,000 members), MethodistCare’s Houston, Texas business in January 2002 (11,000 members) and the acquisition of the Medicaid line of business of CCHP of Washington, D.C. in July 2002 (23,000 members). Total membership increased 25.2% to 591,000 as of December 31, 2002 from 472,000 as of December 31, 2001.

      Investment income decreased $2.6 million to $8.0 million for the year ended December 31, 2002. The decrease in investment income is primarily due to the continued decline in market interest rates and increased levels of tax-advantaged securities partially offset by an increase in overall cash and investments levels throughout the year. Cash and investment levels primarily increased due to proceeds from our initial public offering and cash generated from operations.

 
Health benefits

      Expenses relating to health benefits for the year ended December 31, 2002 increased $224.6 million, or 31.7%, to $933.6 million from $709.0 million for the year ended December 31, 2001. The increase was primarily due to the increase in membership. The health benefits ratio, as a percentage of premium revenue, for the year ended December 31, 2002 was 81.0% compared to 80.5% in 2001. The slight increase in the health benefits ratio is primarily due to variations in levels of seasonality from 2001 to 2002 and changes in the mix of members by product.

 
Selling, general and administrative expenses

      Selling, general and administrative expenses increased $23.6 million to $133.4 million for the year ended December 31, 2002 compared to $109.8 million in 2001. The increase in selling, general and administrative expenses was primarily due to an increase in wages and related expenses for additional staff to support our increased membership, expenses related to the implementation and closing of our acquisition of PHP in Florida, expenses related to implementation of HIPAA as well as expenses related to market development activities. Our selling, general and administrative expense ratio to revenue was 11.5% and 12.3% for the year ended December 31, 2002 and 2001, respectively. The decrease in the ratio was a result of economies of scale and of fixed costs being spread over a larger membership base.

30


Table of Contents

 
Interest expense

      Interest expense was $0.8 million for each of the years ended December 31, 2002 and 2001.

 
Provision for income taxes

      Income tax expense for 2002 was $32.7 million with an effective tax rate of 41.0% as compared to $26.1 million in 2001 and an effective tax rate of 42.0%. The effective tax rate decreased in 2002 due primarily to increased levels of investments in tax-advantaged securities.

 
Net income

      Net income for 2002 rose $10.9 million to $47.0 million, or $2.19 per diluted share, compared to $36.1 million, or $2.08 per diluted share in 2001. Diluted earnings per share rose only 5.3% as compared to an increase in net income of 30.2% due to the increase in shares outstanding which is primarily the result of the issuance of 4,985,000 shares from our November 2001 initial public offering.

Liquidity and Capital Resources

      Our primary sources of liquidity are cash and cash equivalents, short and long-term investments, cash flow from operations and borrowings under our credit facility. As of December 31, 2003, we had cash and cash equivalents of $407.2 million, short and long-term investments of $127.9 million and restricted investments on deposit for licensure of $35.3 million. As of December 31, 2003, there were no borrowings outstanding under our $95.0 million credit facility. Cash and investments totaled $535.1 million at December 31, 2003. A portion of this cash is regulated by state capital requirements. However, $199.9 million of our cash and investments were unregulated and held at the parent level.

      On October 16, 2003, we completed a public offering of 3,162,500 shares of common stock at $46.50 per share, including an over-allotment issuance of 412,500 shares. Net proceeds from the offering, after fees and expenses, were approximately $138.8 million. On October 21, 2003, we used $30.0 million of proceeds from the offering to repay the outstanding balance under our credit facility.

      Cash flows from operations was $128.4 million for the year ended December 31, 2003 compared to $117.9 million for the year ended December 31, 2002. The increase in cash from operations is primarily due to the impact of an early receipt of premium revenue received in 2003 attributable to operations in 2004 and increases in depreciation and amortization expense. As of December 31, 2003, we had working capital of $127.6 million.

      Cash used in investing activities decreased to $27.8 million for the year ended December 31, 2003 from $143.5 million for the year ended December 31, 2002. The decrease in cash used in investing activities was primarily due to an escrow deposit made in connection with the acquisition of PHP and related costs of $124.1 million in 2002. We currently anticipate that our 2004 capital expenditures will be approximately $34 million.

      Our investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets. As of December 31, 2003, our investment portfolio consisted primarily of fixed-income securities. The weighted average maturity is less than six months. We utilize investment vehicles such as municipal bonds, commercial paper, U.S. government backed agencies, auction rate securities and U.S. Treasury instruments. The states in which we operate prescribe the types of instruments in which our subsidiaries may invest their cash. The weighted average taxable equivalent yield on consolidated investments as of December 31, 2003 was approximately 1.56%.

      Cash provided by financing activities was $98.6 million and $49.8 million for the year ended December 31, 2003 and December 31, 2002, respectively. Cash provided by financing activities in 2003 consisted primarily of net proceeds from our public offering of $138.8 million partially offset by $50.0 million in repayments of borrowings under our credit facility. Cash provided by financing activities in 2002 consisted primarily of proceeds from our credit facility of $50.0 million.

31


Table of Contents

      On October 22, 2003, we entered into a $95.0 million Amended and Restated Credit Agreement with Bank of America, N.A., Wachovia Bank, National Association, Credit Suisse First Boston and CIBC World Markets Corp. The Credit Agreement contains a provision which allows us to obtain, subject to certain conditions, an increase in revolving commitments of up to an additional $30.0 million. The proceeds of the Credit Agreement are available for general corporate purposes, including, without limitation, permitted acquisitions of businesses, assets and technologies. The borrowings under the Credit Agreement will accrue interest at one of the following rates, at our option: Eurodollar plus the applicable margin or an alternate base rate plus the applicable margin. The applicable margin for Eurodollar borrowings is between 2.00% and 2.50% and the applicable margin for alternate base rate borrowings is between 1.00% and 1.50%. The applicable margin will vary depending on our leverage ratio. The Credit Agreement is secured by the assets of AMERIGROUP Corporation and by the commons stock of its direct, wholly owned subsidiaries. There is a commitment fee on the unused portion of the Credit Agreement that ranges from 0.375% to 0.50%, depending on the leverage ratio. The Credit Agreement terminates on October 22, 2006.

      Our subsidiaries are required to maintain minimum statutory capital requirements prescribed by various jurisdictions, including the departments of insurance in each of the states in which we operate. As of December 31, 2003, our subsidiaries were in compliance with all minimum statutory capital requirements. We believe that we will continue to be in compliance with these requirements for the next twelve months.

      We believe that internally generated funds and available funds under our revolving credit facility will be sufficient to support continuing operations, capital expenditures and our growth strategy for at least 12 months.

      The following table summarizes our material contractual obligations, including both on- and off-balance sheet arrangements, and our commitments at December 31, 2003 (in thousands):

                                                             
Contractual Obligations Total 2004 2005 2006 2007 2008 Thereafter








Lease financing:
                                                       
 
Operating lease obligations
  $ 62,848     $ 8,309     $ 8,234     $ 7,893     $ 6,941     $ 4,895     $ 26,576  
 
Capital lease obligations
    11,334       4,794       3,589       1,675       868       408        
     
     
     
     
     
     
     
 
   
Total lease financing
  $ 74,182     $ 13,103     $ 11,823     $ 9,568     $ 7,809     $ 5,303     $ 26,576  
     
     
     
     
     
     
     
 
                                                         
Long-term Borrowings

Credit agreement
  $     $     $     $     $     $     $  
     
     
     
     
     
     
     
 
                                                           
Expiring in Expiring in Expiring in Expiring in Expiring in
Commitments Total 2004 2005 2006 2007 2008 Thereafter








Purchase obligations
  $ 8,579     $ 8,579     $     $     $     $     $  
Lease guarantee related to Florida office space
    844       676       168                          
     
     
     
     
     
     
     
 
 
Total commitments
  $ 9,423     $ 9,255     $ 168     $     $     $     $  
     
     
     
     
     
     
     
 

Lease Financing

      Operating Lease Obligations. Our operating lease obligations are primarily for payments under non-cancelable office space leases.

      Capital Lease Obligations. Our capital lease obligations are primarily related to leased furniture, fixtures and equipment. The terms of these leases are normally between three and five years.

Long-term Borrowings

      Credit Agreement. On October 22, 2003, we entered into a $95.0 million Amended and Restated Credit Agreement (Credit Agreement) with a syndicate of banks. The Credit Agreement contains a provision which allows us to obtain, subject to certain conditions, an increase in revolving commitments of up to an additional

32


Table of Contents

$30.0 million. The proceeds of the Credit Agreement are available for general corporate purposes, including, without limitation, permitted acquisitions of businesses, assets and technologies. The commitment fee on the unused portion of the Credit Agreement ranges from 0.375% to 0.50%, depending on our leverage ratio. The Credit Agreement terminates on October 22, 2006 and was undrawn as of December 31, 2003.

Commitments

      Purchase Obligations. Under certain contracts, we are committed to spend approximately $8.6 million on software licensing and implementation expenses for our new claims payment system and leasehold improvements relating to a new building under construction in Virginia Beach, Virginia that we will begin leasing in 2004.

      Lease Guarantee. In connection with our acquisition of PHP, we agreed to guarantee a certain lease for office space operated by the former management of PHP. The lease term ends in March 2005.

Regulatory Capital and Dividend Restrictions

      Our operations are conducted through our wholly owned subsidiaries, which include HMOs and one managed care organization, or MCO. HMOs and MCOs are subject to state regulations that, among other things, may require the maintenance of minimum levels of statutory capital, as defined by each state, and restrict the timing, payment and amount of dividends and other distributions that may be paid to their stockholders. Additionally, state regulatory agencies may require individual HMO’s to maintain statutory capital levels higher than the state regulations. As of December 31, 2003, we believe our subsidiaries are in compliance with all minimum statutory capital requirements. We believe that we will continue to be in compliance with these requirements at least through the end of 2004.

      As of December 31, 2003, our subsidiaries had aggregate statutory capital and surplus of approximately $106.9 million, compared with the required minimum aggregate statutory capital and surplus requirements of approximately $63.1 million.

      The National Association of Insurance Commissioners, or NAIC, has adopted rules which, to the extent that they are implemented by the states, set new minimum net worth requirements for insurance companies, HMOs and other entities bearing risk for health care coverage. The requirements take the form of risk-based capital rules. The change in rules for insurance companies became effective as of December 31, 1998. Illinois, Texas and the District of Columbia adopted various forms of the rules as of December 31, 1999, 2000 and 2003, respectively. Since our Maryland subsidiary is licensed in both the District of Columbia and Maryland, the highest risk-based capital requirement between the two will prevail. New Jersey and Florida have not yet adopted risk-based capital as their net worth requirements. The NAIC’s HMO rules, if adopted by these states in their proposed form, may increase the minimum capital required for our subsidiaries. Effective December 31, 2003, these plans are required to maintain a statutory capital level greater than the state regulations.

Inflation

      Although the general rate of inflation has remained relatively stable and health care cost inflation has stabilized in recent years, the national health care cost inflation rate still exceeds the general inflation rate. We use various strategies to mitigate the negative effects of health care cost inflation. Specifically, our health plans try to control medical and hospital costs through contracts with independent providers of health care services. Through these contracted care providers, our health plans emphasize preventive health care and appropriate use of specialty and hospital services.

      While we currently believe our strategies to mitigate health care cost inflation will continue to be successful, competitive pressures, new health care and pharmaceutical product introductions, demands from health care providers and customers, applicable regulations or other factors may affect our ability to control the impact of health care cost increases.

33


Table of Contents

Off-Balance Sheet Arrangements

      The Company’s off-balance sheet arrangements include future minimum rental commitments of $62.8 million and a lease guarantee of $0.8 million, both of which are disclosed in Note 12(c) to the consolidated financial statements. The Company has no investments, loans or any other known contractual arrangements with special-purpose entities, variable interest entities or financial partnerships.

Compliance Costs

      The federal regulations promulgated under HIPAA relating to privacy, standard transactions and security were issued in proposed form in 1998. We met the compliance date of April 2003 for privacy rules and must comply by October 16, 2003 for transactions and April 2005 for security. The final security rule was issued in February 2003 and we have not fully assessed the cost of complying with these regulations. The fact that either state or federal rules may supersede the other, depending on the nature of the particular requirement, will require interpretations for which there is likely to be little precedent. We have implemented the programs and systems that were required for compliance with the new privacy regulations by April 2003 and continue work for transactions and security compliance. In order to comply with the requirements, we will have to employ additional or different programs and systems. We had expenses of approximately $2.5 million on HIPAA compliance in 2002. For 2003, we had expenses of approximately $2.6 million on HIPAA compliance. Additional costs will be incurred in 2004 in complying with the security regulations which require compliance by April 2005. We are in the process of interpreting the security regulations and cannot estimate the cost of compliance at this time. We expect to be fully compliant by the required dates. Further, compliance with these regulations are requiring changes to many of the procedures we currently use to conduct our business, which may lead to additional costs that we have not yet identified. We do not know whether, or the extent to which, we will be able to recover from the states our costs of complying with these new regulations.

 
Item 7A. Quantitative and Qualitative Disclosures About Market Risk

      As of December 31, 2003 we had short-term investments of $8.8 million, long-term investments of $119.1 million and investments on deposit for licensure of $35.3 million. These investments consist of highly liquid investments with maturities between three and twenty-four months. These investments are subject to interest rate risk and will decrease in value if market rates increase. Credit risk is managed by investing in money market funds, U.S. Treasury securities, cash escrow accounts, asset-backed securities, debt securities of government sponsored entities, municipal bonds and auction rate securities. Our investment policies are subject to revision based upon market conditions and our cash flow and tax strategies, among other factors. We have the ability to hold these investments to maturity, and as a result, we would not expect the value of these investments to decline significantly as a result of a sudden change in market interest rates. As of December 31, 2003, a hypothetical 1% change in interest rates would result in an approximate $1.6 million change in our annual investment income.

34


Table of Contents

RISK FACTORS

Risks related to being a regulated entity

 
Changes in government regulations designed to protect providers and members rather than our stockholders could force us to change how we operate and could harm our business.

      Our business is extensively regulated by the states in which we operate and by the federal government. These laws and regulations are generally intended to benefit and protect providers and health plan members rather than stockholders. Changes in existing laws and rules, the enactment of new laws and rules and changing interpretations of these laws and rules could, among other things:

  •  force us to change how we do business,
 
  •  restrict revenue and enrollment growth,
 
  •  increase our health benefits and administrative costs,
 
  •  impose additional capital requirements, and
 
  •  increase or change our liability.

      For example, in Texas, our health care operations may be affected by laws passed in the 2003 Texas legislative session, as well as new regulations adopted by the Texas Department of Insurance, which became effective in October 2002. The new laws include:

  •  a requirement that premium and maintenance taxes apply to Medicaid and SCHIP programs,
 
  •  new disclosure requirements regarding provider fee schedules and coding procedures,
 
  •  more stringent prompt pay requirements that may become applicable to Medicaid and SCHIP programs,
 
  •  new requirements for establishing a special investigative unit to investigate fraudulent claims, and
 
  •  new requirements for monitoring and supervising the activities of provider groups.

 
If state regulators do not approve payments of dividends, distributions or administrative fees by our subsidiaries to us, it could negatively affect our business strategy.

      We principally operate through our health plan subsidiaries. These subsidiaries are subject to regulations that limit the amount of dividends and distributions that can be paid to us without prior approval of, or notification to, state regulators. We also have administrative services agreements with our subsidiaries in which we agree to provide them with services and benefits (both tangible and intangible) in exchange for the payment of a fee. If the regulators were to deny our subsidiaries’ requests to pay dividends to us or restrict or disallow the payment of the administrative fee, the funds available to our company as a whole would be limited, which could harm our ability to implement our business strategy.

 
Regulations could limit our profits as a percentage of revenues.

      Our New Jersey and Maryland subsidiaries are subject to minimum medical expense levels as a percentage of premium revenue. In New Jersey, contractual sanctions may be imposed if these levels are not met. In addition, our Texas plans are required to pay a rebate to the state in the event profits exceed established levels. These regulatory requirements, changes in these requirements and additional requirements by our other regulators could limit our ability to increase our overall profits as a percentage of revenues, which could harm our operating results. We have been required, and may in the future be required, to make payments to the states as a result of not meeting these expense and profit levels.

35


Table of Contents

 
Our failure to comply with government regulations could subject us to civil and criminal penalties and limitations on our profitability.

      Violation of the laws or regulations governing our operations could result in the imposition of sanctions, the cancellation of our contracts to provide services, or in the extreme case, the suspension or revocation of our licenses. For example, in two markets in which we operate we are required to spend a minimum percentage of our premium revenue on medical expenses. In one market, if we fail to comply with this requirement, we could be required to pay monetary damages. Additionally, we could be required to file a corrective plan of action with the state and we could be subject to further fines and additional corrective measures if we did not comply with the corrective plan of action. In the other market, our failure to comply could affect future rate determinations. These regulations could limit the profits we can obtain.

      While we have not been subject to any fines or violations that were material, we cannot assure you that we will not become subject to material fines or other sanctions in the future. If we became subject to material fines or if other sanctions or other corrective actions were imposed upon us, our ability to continue to operate our business could be materially and adversely affected.

      In the past we have been subject to sanctions as a result of violations of marketing regulations and timeliness of the payment requirements. For example, in August 2000, our Illinois plan received a sanction for violations of marketing rules. In 2003, our Florida plan was fined for marketing violations that occurred prior to and shortly after the acquisition of PHP Holdings, Inc. and its subsidiary, Physician Healthcare Plans, Inc., together PHP. In New Jersey, from time-to-time, we are fined for failing to meet the timeliness of payment requirements. Additionally, in July 2003, our New Jersey subsidiary received a notice of deficiency for failure to maintain provider network requirements in one New Jersey county as required by our Medicaid contract with New Jersey. We submitted to the State a corrective action plan and a request for a waiver of certain contractual provisions on August 10, 2003. On October 3, 2003, the State of New Jersey denied our request for a waiver, but granted an extension until November 28, 2003 to correct the network deficiency. Prior to the expiration of this extension, AMERIGROUP requested and received an additional extension to January 30, 2004 at which time AMERIGROUP requested a waiver to certain network requirements. AMERIGROUP is awaiting a determination by the State of New Jersey on its requested waiver. There can be no assurances that such a waiver will be granted.

      On October 12, 2001, we responded to a Civil Investigative Demand, or CID, of the HMO industry by the Office of the Attorney General of the State of Texas relating to processing of provider claims. We understand from the Office of the Attorney General that responses were required from the nine largest HMOs in Texas, of which we are the ninth. The other eight are HMOs that primarily provide commercial products. The CID is being conducted in connection with allegations of unfair contracting, delegating and payment practices and violations of the Texas Deceptive Trade Practices — Consumer Protection Act and article 21.21 of the Texas Insurance Code by HMOs. In meetings with representatives of the Attorney General, they agreed that our required response would be limited to providing information relating to our payment of hospital claims only. In addition, based upon our discussions with the Office of the Attorney General, it is our understanding that we are not currently the target of any investigation by that Office. On October 19, 2001 we filed our response to the CID including all information that we believed was required to be produced. On October 26, 2001, we received a request from the Office of the Attorney General that we clarify and supplement certain of our responses. We responded with a second filing on December 21, 2001 and supplemental filings thereafter. These additional filings were materials provided for clarification of the original submission and were not the result of an expansion of the scope of the CID. The Office of the Attorney General could request additional information or clarification that could be costly and time consuming for us to produce.

      The Health Insurance Portability and Accountability Act of 1996, or HIPAA, broadened the scope of fraud and abuse laws applicable to health care companies. HIPAA created civil penalties for, among other things, billing for medically unnecessary goods or services. HIPAA establishes new enforcement mechanisms to combat fraud and abuse, including a whistle-blower program. Further, a new regulation promulgated pursuant to HIPAA imposes civil and criminal penalties for failure to comply with the health records privacy standards set forth in the regulation. The Department of Health and Human Services, or HHS, press release related to the new regulation calls on Congress to enact legislation to “fortify” penalties and to create a private right of action under HIPAA.

36


Table of Contents

Although no such penalties or private cause of action have yet been created, we do not know when or if such sanctions may be enacted. HHS also issued its interim fiscal rule on enforcement of the privacy regulations in April 2003. Enforcement of the privacy regulations is handled under the Office of Civil Rights.

      The federal government has enacted, and state governments are enacting, other fraud and abuse laws as well. Our failure to comply with HIPAA or these other laws could result in criminal or civil penalties and exclusion from Medicaid or other governmental health care programs and could lead to the revocation of our licenses. These penalties or exclusions, were they to occur, would negatively impact our ability to operate our business.

 
Compliance with new federal and state rules and regulations may require us to make unanticipated expenditures.

      In August 2000, HHS issued a new regulation under HIPAA requiring the use of uniform electronic data transmission standards for health care claims and payment transactions submitted or received electronically. We and the other health organizations that filed a written compliance plan by October 2002 were required to comply with the new transactions regulation by October 16, 2003. In July 2003, CMS issued its guidance on the October 2003 compliance deadline for the HIPAA transactions and code set rules, stating that enforcement by CMS will be on a complaint-driven basis. Also in August 2000, HHS proposed a regulation that would require health care participants to implement organizational and technical practices to protect the security of electronically maintained or transmitted health-related information. This security regulation, finalized in February 2003, requires compliance by April 2005. In December 2000, HHS issued a new regulation mandating heightened privacy and confidentiality protections under HIPAA, which became effective on April 14, 2001 and which required full compliance on or before April 14, 2003. To the extent that state laws impose stricter privacy standards than the HIPAA privacy regulations or to the extent that a state seeks and receives an exception from HHS regarding certain state laws, such laws will not be preempted.

      The states’ ability to promulgate stricter rules regarding privacy and uncertainty regarding many aspects of the regulations make compliance with the relatively new regulatory landscape difficult. Our existing programs and systems may not enable us to comply in all respects with these new regulations. We have implemented the programs and systems that are required for compliance with the new privacy regulations. In order to comply with the regulatory requirements, we were required to employ additional or different programs and systems. We had expenditures of approximately $2.6 million and $2.5 million on HIPAA compliance in 2003 and 2002, respectively. Additional costs may be incurred in 2004 in complying with the security regulations which require compliance by April 2005 and with the transaction standards regulations, which are currently being implemented in accordance with our contingency plans. We are in the process of interpreting the security regulations and cannot estimate the cost of compliance at this time. We expect to be fully compliant by the required dates. Further, compliance with these pervasive regulations will require changes to many of the procedures we currently use to conduct our business, which may lead to additional costs that we have not yet identified. We do not know whether, or the extent to which, we will be able to recover our costs of complying with these new regulations from the states. The new regulations and related costs to comply with the new regulations could have a material adverse effect on our business. In addition, failure to comply with the new regulations could also have a material adverse effect on our business.

      In January 2001, CMS published new federal regulations regarding Medicaid managed care. On June 14, 2002, CMS published final regulations that replaced the January regulations in their entirety. The final regulations implement requirements of the Balanced Budget Act of 1997 that are intended to give states more flexibility in their administration of Medicaid managed care programs, provide certain new patient protections for Medicaid managed care enrollees, and require states’ rates to meet new actuarial soundness requirements. The effective date for compliance with the regulation was August 13, 2003, with an extension provided to states operating under an 1115 demonstration waiver with a three-year BBA extension. If states fail to comply with the new regulations they could lose their funding from the federal fund matching program. The new regulations have been reflected in amendments in our contracts or new contracts with the Medicaid agencies in our various markets, with the exception of the Maryland market which currently operates under the 1115 demonstration waiver with the BBA extension. Compliance with these new provisions have required changes to many of the

37


Table of Contents

procedures we currently use to conduct our business, which may lead to additional costs that we have not yet identified.
 
Changes in health care laws could reduce our profitability.

      Numerous proposals relating to changes in health care law have been introduced, some of which have been passed by Congress and the states in which we operate or may operate in the future. Changes in applicable laws and regulations are continually being considered and interpretations of existing laws and rules may also change from time to time. We are unable to predict what regulatory changes may occur or what effect any particular change may have on our business. Although some of the recent changes in government regulations, such as the removal of the requirements on the enrollment mix between commercial and public sector membership, have encouraged managed care participation in public sector programs, we are unable to predict whether new laws or proposals will continue to favor or hinder the growth of managed health care.

      An example is state and federal legislation that would enable physicians to collectively bargain with managed health care organizations. The legislation, as currently proposed, generally contains an exemption for public sector managed health care organizations. If legislation of this type were passed without this exemption, it would negatively impact our bargaining position with many of our providers and might result in an increase in our cost of providing medical benefits.

      We cannot predict the outcome of these legislative or regulatory proposals, nor the effect which they might have on us. Legislation or regulations that require us to change our current manner of operation, provide additional benefits or change our contract arrangements could seriously harm our operations and financial results.

 
Changes in federal funding mechanisms could reduce our profitability.

      As part of the current Administration’s 2004 Budget submission to Congress, HHS announced principles for Medicaid reform. HHS’s proposal would have established two capped allotments for the states combining both Medicaid and SCHIP funds, one for acute care and one for long-term care. Under this proposal, all mandatory populations and benefits would continue to be covered as required under current law. States, however, would be given flexibility for optional populations and benefits. The proposal would be revenue-neutral over a ten-year period, although states would receive an additional $13.0 billion over the first seven years, with corresponding funding reductions in years eight through ten.

      The proposal was meant to provide increased flexibility to the states in managing their Medicaid and SCHIP programs, in particular in the design of benefit packages for optional populations. Governors working in concert with HHS were unable to reach agreement on these principles and the proposal was set aside for the time being. It is uncertain as to when, if at all, this proposal, or a variation thereof, will be enacted. Congress instead passed a $20.0 billion fiscal relief program for the states, which included a $10.0 billion increase in the share of medical assistance expenditures under each state’s Medicaid program, known as FMAP.

      If HHS’s proposal is ultimately adopted and the number of persons enrolled in Medicaid or SCHIP decreases in the states in which we operate or the volume of health care services provided is reduced, our growth, operations and financial performance could be adversely affected.

 
Reductions in Medicaid funding by the states could substantially reduce our profitability.

      Most of our revenues come from state government Medicaid premiums. The base premium rate paid by each state differs, depending on a combination of various factors such as defined upper payment limits, a member’s health status, age, gender, county or region, benefit mix and member eligibility categories. Future levels of Medicaid premium rates may be affected by continued government efforts to contain medical costs and may further be affected by state and federal budgetary constraints. Changes to Medicaid programs could reduce the number of persons enrolled or eligible, reduce the amount of reimbursement or payment levels, or increase our administrative or health care costs under such programs. States periodically consider reducing or reallocating the amount of money they spend for Medicaid. We believe that additional reductions in Medicaid payments could substantially reduce our profitability. Further, our contracts with the states are subject to cancellation by the state

38


Table of Contents

in the event of unavailability of state funds. In some jurisdictions, such cancellation may be immediate and in other jurisdictions a notice period is required.

      State governments generally are experiencing budgetary shortfalls. Budget problems in the states in which we operate could result in limited increases or even decreases in the premiums paid to us by the states. The State of Illinois, which accounts for approximately 4% of our total enrollment as of December 31, 2003, reduced the Medicaid premiums it pays to us by approximately 5% in 2003 and 6% in 2002, due to state budgetary concerns. If any state in which we operate were to decrease premiums paid to us, or pay us less than the amount necessary to keep pace with our cost trends, it could have a material adverse effect on our profitability.

 
If state governments do not renew our contracts with them on favorable terms, our business will suffer.

      As of December 31, 2003, we served members who received health care benefits through 13 contracts with the regulatory entities in the jurisdictions in which we operate. Five of these contracts, which are with the states of Texas, Florida, Maryland and New Jersey individually accounted for 10% or more of our revenues for the year ended December 31, 2003, with the largest of these contracts representing approximately 20% of our revenues. If any of our contracts were not renewed on favorable terms or were terminated for cause or if we were to lose a contract in a re-bidding process, our business would suffer. All our contracts have been extended until at least mid-2004 Termination or non-renewal of any single contract could materially impact our revenues and operating results.

      Some of our contracts are subject to a re-bidding process. For example, we are subject to a re-bidding process in each of our three Texas markets and for our SCHIP contracts in each of our three Florida markets. Our Texas markets are re-bid every six years and the re-bidding process is scheduled to occur in 2004. In Florida, six of eight counties currently under contract were re-bid in April 2003. Our re-bid resulted in the retention of four current counties and our selection as a new carrier in two additional counties. The Florida SCHIP contracts are re-bid every two or four years. If we lost a contract through the re-bidding process, our operating results could be materially and adversely affected.

 
If a state fails to renew its federal waiver application for mandated Medicaid enrollment into managed care or such application is denied, our membership in that state will likely decrease.

      States may only mandate Medicaid enrollment into managed care under federal waivers or demonstrations. Waivers and programs under demonstrations are approved for two-year periods and can be renewed on an ongoing basis if the state applies. We have no control over this renewal process. If a state does not renew its mandated program or the federal government denies the state’s application for renewal, our business would suffer as a result of a likely decrease in membership.

 
We rely on the accuracy of eligibility lists provided by the state government. Inaccuracies in those lists would negatively affect our results of operations.

      Premium payments to us are based upon eligibility lists produced by the state government. From time-to-time, states require us to reimburse them for premiums paid to us based on an eligibility list that a state later discovers contains individuals who are not in fact eligible for a government sponsored program or are eligible for a different premium category or a different program. Alternatively, a state could fail to pay us for members for whom we are entitled to payment. Our results of operations would be adversely affected as a result of such reimbursement to the state if we had made related payments to providers and were unable to recoup such payments from the providers.

 
If state regulatory agencies require a statutory capital level higher than the state regulations we may be required to make additional capital contributions.

      Our operations are conducted through our wholly owned subsidiaries, which include HMOs and one managed care organization, or MCO. HMOs and MCOs are subject to state regulations that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state. Additionally, state regulatory agencies may require, at their discretion, individual HMO’s to maintain statutory capital levels higher

39


Table of Contents

than the state regulations. If this were to occur to one of our subsidiaries, we may be required to make additional capital contributions to the affected subsidiary. Any additional capital contribution made to one of the affected subsidiaries could have a material adverse effect on our liquidity and our ability to grow.

Risks related to our business

 
Receipt of inadequate or significantly delayed premiums would negatively impact our revenues, profitability and cash flow.

      Most of our revenues are generated by premiums consisting of fixed monthly payments per member. These premiums are fixed by contract, and we are obligated during the contract period to facilitate access to health care services as established by the state governments. We have less control over costs related to the provision of health care than we do over our selling, general and administrative expenses. Historically, our expenses related to health benefits as a percentage of premium revenue have fluctuated. For example, our expenses related to health benefits were 80.2% of our premium revenue in 2003, and 81.0% of our premium revenue in 2002. If premiums are not increased and expenses related to health benefits rise, our earnings could be impacted negatively. In addition, our actual health benefits costs may exceed our estimated costs. The premiums we receive under our current contracts may therefore be inadequate to cover all claims, which could cause our profits to decline.

      Maryland sets the rates that must be paid to hospitals by all payors. It is possible for the state to increase rates payable to the hospitals without granting a corresponding increase in premiums to us. If this were to occur, or if other states were to take similar actions, our profitability would be harmed.

      Premiums are contractually payable to us before or during the month for services that we are obligated to provide to our members. Our cash flow would be negatively impacted if premium payments are not made according to contract terms.

 
Our inability to manage medical costs effectively would reduce our profitability.

      Our profitability depends, to a significant degree, on our ability to predict and effectively manage medical costs. Changes in health care regulations and practices, level of use of health care services, hospital costs, pharmaceutical costs, major epidemics, new medical technologies and other external factors, including general economic conditions such as inflation levels, are beyond our control and could reduce our ability to predict and effectively control the costs of health care services. Although we have been able to manage medical costs through a variety of techniques, including various payment methods to primary care physicians and other providers, advance approval for hospital services and referral requirements, medical management and quality management programs, our information systems and reinsurance arrangements, we may not be able to continue to manage costs effectively in the future. It is possible that claims previously denied and claims previously paid to non-network providers will be appealed and subsequently reprocessed at different amounts. This would result in an adjustment to claims expense. If our costs for medical services increase, our profits could be reduced, or we may not remain profitable.

 
Our limited ability to predict our incurred medical expenses accurately could negatively impact our reported results.

      Our medical expenses include estimates of medical expenses incurred but not yet reported, or IBNR. We estimate our IBNR medical expenses based on a number of factors, including authorization data, prior claims experience, maturity of markets, complexity and mix of products and stability of provider networks. Adjustments, if necessary, are made to medical expenses in the period during which the actual claim costs are ultimately determined or when criteria used to estimate IBNR change. We utilize the services of independent actuaries who are contracted on a regular basis to calculate and review the adequacy of our medical liabilities, in addition to using our internal resources. We cannot be sure that our IBNR estimates are adequate or that adjustments to such IBNR estimates will not harm our results of operations. Further, our inability to accurately estimate IBNR may also affect our ability to take timely corrective actions, further exacerbating the extent of the harm on our results.

40


Table of Contents

      We maintain reinsurance to protect us against severe or catastrophic medical claims, but we cannot assure you that such reinsurance coverage will be adequate or available to us in the future or that the cost of such reinsurance will not limit our ability to obtain it.

 
Difficulties in executing our acquisition strategy or integrating acquired business could adversely affect our business.

      Historically, acquisitions including the acquisition of Medicaid contract rights and related assets of other health plans, both in our existing service areas and in new markets, has accounted for a significant amount of our growth. Although we cannot predict our rate of growth as the result of acquisitions with complete accuracy, we believe that acquisitions similar in nature to those we have historically executed will be important to our growth strategy. Many of the other potential purchasers of these assets have greater financial resources than we have. In addition, many of the sellers are interested in either (1) selling, along with their Medicaid assets, other assets in which we do not have an interest; or (2) selling their companies, including their liabilities, as opposed to just the assets of the ongoing business. Therefore, we cannot be sure that we will be able to complete acquisitions on terms favorable to us or that we can obtain the necessary financing for these acquisitions.

      We are currently evaluating potential acquisitions that would increase our membership, as well as acquisitions of complementary health care service businesses. These potential acquisitions are at various stages of consideration and discussion and we may enter into letters of intent or other agreements relating to these proposals at any time. However, we cannot predict when or whether we will actually acquire these businesses.

      We are generally required to obtain regulatory approval from one or more state agencies when making acquisitions. In the case of an acquisition of a business located in a state in which we do not currently operate, we would be required to obtain the necessary licenses to operate in that state. In addition, although we may already operate in a state in which we acquire a new business, we will be required to obtain additional regulatory approval if, as a result of the acquisition, we will operate in an area of the state in which we did not operate previously. There can be no assurance that we would be able to comply with these regulatory requirements for an acquisition in a timely manner, or at all.

      Our existing credit facility imposes certain restrictions on acquisitions. We may not be able to meet these restrictions.

      In addition to the difficulties we may face in identifying and consummating acquisitions, we will also be required to integrate our acquisitions with our existing operations. This may include the integration of:

  •  additional employees who are not familiar with our operations,
 
  •  existing provider networks, which may operate on different terms than our existing networks,
 
  •  existing members, who may decide to switch to another health care provider, and
 
  •  disparate information and record keeping systems.

      We may be unable to successfully identify, consummate and integrate future acquisitions, including integrating the acquired businesses on to our technology platform, or to implement our operations strategy in order to operate acquired businesses profitably. We also may be unable to obtain sufficient additional capital resources for future acquisitions. There can be no assurance that incurring expenses to acquire a business will result in the acquisition being consummated. These expenses could impact our selling, general and administrative expense ratio. If we are unable to effectively execute our acquisition strategy or integrate acquired businesses, our future growth will suffer and our results of operations could be harmed.

 
Failure of a new business would negatively impact our results of operations.

      Start-up costs associated with a new business can be substantial. For example, in order to obtain a certificate of authority in most jurisdictions, we must first establish a provider network, have systems in place and demonstrate our ability to be able to obtain a state contract and process claims. If we were unsuccessful in obtaining the necessary license, winning the bid to provide service or attracting members in numbers sufficient to

41


Table of Contents

cover our costs, the new business would fail. We also could be obligated by the state to continue to provide services for some period of time without sufficient revenue to cover our ongoing costs or recover start-up costs. The loss of the costs associated with starting up the business could have a significant impact on our results of operations.
 
Ineffective management of rapid growth or our inability to grow could negatively affect our results of operations, financial condition and business.

      We have experienced rapid growth. In 1996, our first full year of operations, we had $22.9 million of premium revenue. In 2003, we had $1,615.5 million in premium revenue. This increase represents a compound annual growth rate of 83.7%.

      Depending on acquisition and other opportunities, we expect to continue to grow rapidly. Continued growth could place a significant strain on our management and on other resources. We anticipate that continued growth, if any, will require us to continue to recruit, hire, train and retain a substantial number of new and highly skilled medical, administrative, information technology, finance and other support personnel. Our ability to compete effectively depends upon our ability to implement and improve operational, financial and management information systems on a timely basis and to expand, train, motivate and manage our work force. If we continue to experience rapid growth, our personnel, systems, procedures and controls may be inadequate to support our operations, and our management may fail to anticipate adequately all demands that growth will place on our resources. In addition, due to the initial costs incurred upon the acquisition of new businesses, rapid growth could adversely affect our short-term profitability. Our inability to manage growth effectively or our inability to grow could have a negative impact on our business, operating results and financial condition.

 
We are subject to competition that impacts our ability to increase our penetration of the markets that we service.

      We compete for members principally on the basis of size and quality of provider network, benefits provided and quality of service. We compete with numerous types of competitors, including other health plans and traditional state Medicaid programs that reimburse providers as care is provided. Some of the health plans with which we compete have substantially larger enrollments, greater financial and other resources and offer a broader scope of products than we do.

      While many states mandate health plan enrollment for Medicaid eligible participants, the programs are voluntary in other states, such as Illinois. Subject to limited exceptions by federally approved state applications, the federal government requires that there be choice for Medicaid recipients among managed care programs. Voluntary programs and mandated competition will impact our ability to increase our market share.

      In addition, in most states in which we operate we are not allowed to market directly to potential members, and therefore, we rely on creating name brand recognition through our community-based programs. Where we have only recently entered a market or compete with health plans much larger than we are, we may be at a competitive disadvantage unless and until our community-based programs and other promotional activities create brand awareness.

 
Restrictions and covenants in our credit facility could limit our ability to take actions.

      On October 22, 2003, we entered into a new $95.0 million Amended and Restated Credit Agreement with four lenders. The credit facility contains a provision which allows us to obtain, subject to certain conditions, an increase in revolving commitments of up to an additional $30.0 million. Our Credit Agreement is secured by the assets of AMERIGROUP and by the common stock of its direct, wholly owned subsidiaries. Pursuant to the Credit Agreement, we must meet certain financial covenants. As of December 31, 2003, we were in compliance with such covenants. These financial covenants include meeting certain financial ratios, a limit on annual capital expenditures, and a minimum net worth requirement. As of December 31, 2003, the credit facility was undrawn.

      Events beyond our control, such as prevailing economic conditions and changes in the competitive environment, could impair our operating performance, which could affect our ability to comply with the terms of

42


Table of Contents

the credit facility. Breaching any of the covenants or restrictions could result in the unavailability of the facility or a default under the credit facility. We cannot assure you that our assets or cash flow will be sufficient to fully repay outstanding borrowings under the credit facility or that we would be able to restructure such indebtedness on terms favorable to us. If we were unable to repay, refinance or restructure our indebtedness under the credit facility, the lenders could proceed against the collateral securing the indebtedness.
 
The loss of the services of our Chairman of the Board of Directors and Chief Executive Officer would harm our operations; our inability to find a suitable replacement for our Chief Financial Officer could negatively impact our business.

      We are highly dependent on the efforts of Mr. Jeffrey McWaters, our Chairman of the Board of Directors and Chief Executive Officer. Mr. McWaters, as our founder, has been instrumental in developing our mission and forging our relationships with our government client-customers and the communities we serve. We cannot assure you that we will be able to retain Mr. McWaters or attract a suitable replacement or additional personnel if required. We have an employment agreement with Mr. McWaters that continues from year-to-year unless terminated by either party on 30 days written notice. We cannot be sure that the employment agreement creates sufficient incentives for Mr. McWaters to continue his employment with us. While we believe that we could find a replacement for Mr. McWaters if he were to leave, the loss of his services could harm our operations.

      Our Chief Financial Officer resigned effective October 1, 2003. Although we intend to hire a new Chief Financial Officer, doing so might be difficult or take an extended period of time, which could negatively impact our business.

 
Our inability to maintain satisfactory relationships with providers would harm our profitability.

      Our profitability depends, in large part, upon our ability to contract favorably with hospitals, physicians and other health care providers. Our provider arrangements with our primary care physicians and specialists usually are for one to two-year periods and automatically renew for successive one-year terms, subject to termination by us for cause based on provider conduct or other appropriate reasons. The contracts generally may be canceled by either party upon 90 to 120 days prior written notice. Our contracts with hospitals are usually for one to two-year periods and automatically renew for successive one-year periods, subject to termination for cause due to provider misconduct or other appropriate reasons. Generally, our hospital contracts may be canceled by either party without cause on 90 to 150 days prior written notice. There can be no assurance that we will be able to continue to renew such contracts or enter into new contracts enabling us to service our members profitably. We will be required to establish acceptable provider networks prior to entering new markets. Although we have established long-term relationships with many of our providers, we may be unable to enter into agreements with providers in new markets on a timely basis or under favorable terms. If we are unable to retain our current provider contracts or enter into new provider contracts timely or on favorable terms, our profitability will be harmed.

      On occasion, our members obtain care from providers that are not in our network and with which we do not have contracts. To the extent that we know of such instances, we attempt to redirect their care to a network provider. We have generally reimbursed non-network providers at the rates paid to comparable network providers or at the applicable rate that the provider could have received under the traditional fee-for-service Medicaid program or at a discount therefrom. In some instances, we pay non-network providers pursuant to the terms of our contracts with the State. However, some non-network providers have requested that we pay them at their highest billing rate, or “full-billed charges.” Full-billed charges are significantly more than the amount the non-network providers could otherwise receive under the traditional fee-for-service Medicaid program. Additionally, some non-network providers in New Jersey and Texas have filed lawsuits seeking reimbursements of full-billed charges from us for services they provided to our members. The Texas trial court ruled in November 2003 to abate the lawsuit brought by out-of-network providers pending the providers’ exhaustion of administrative remedies with HHSC. To our knowledge TCH has not initiated an administrative complaint in accordance with the court’s order. However, in March 2004 we received notice that HHSC had commenced a review of certain claims payment issues raised by TCH in early 2002, which are part of the subject matter of the lawsuit.

43


Table of Contents

      On August 8, 2003, the Court ruled against our New Jersey subsidiary. Although no amount of damages has been determined thus far, a notice of motion for summary judgment on damages was filed on September 12, 2003, seeking approximately $8.5 million. The Court denied the motion on December 5, 2003. We have petitioned the Appeals Court for move to file an interlocutory appeal of the Superior Court’s summary judgement on the issue of liability. The petition is currently pending before the appellate division. On February 20, 2004, the court adjourned the March 1, 2004 trial on the issue of damages. To the extent that non-network providers are successful in obtaining payment at rates in excess of the rates that we have historically paid to non-network providers, our profitability could be materially adversely affected. See “Business — Legal Proceedings.”

 
We are dependent on our relationship with Cook Children’s Physician Network. Any material modification or discontinuation of this relationship could harm our results of operations.

      Cook Children’s Physician Network is our exclusive provider network for pediatric services in Fort Worth, where we had approximately 106,000 members as of December 31, 2003. If the terms of our contract with Cook Children’s Physician Network were to change significantly or Cook Children’s Physician Network was to terminate its agreement with us, our costs to provide health care in this area could increase. We could lose members if Cook Children’s Physician Network chose to associate with another HMO or if it obtained its own contract with the state to provide health care services to Medicaid recipients.

 
Negative publicity regarding the managed care industry may harm our business and operating results.

      In the past, the managed care industry has received negative publicity. This publicity has led to increased legislation, regulation, review of industry practices and private litigation in the commercial sector. These factors may adversely affect our ability to market our services, require us to change our services and increase the regulatory burdens under which we operate, further increasing the costs of doing business and adversely affecting our operating results.

 
We may be subject to claims relating to medical malpractice, which could cause us to incur significant expenses.

      Our providers and employees involved in medical care decisions may be exposed to the risk of medical malpractice claims. In addition, some states are considering legislation that permits managed care organizations to be held liable for negligent treatment decisions or benefits coverage determinations. Claims of this nature, if successful, could result in substantial damage awards against us and our providers that could exceed the limits of any applicable insurance coverage. Therefore, successful malpractice or tort claims asserted against us, our providers or our employees could adversely affect our financial condition and profitability.

      In addition, we may be subject to other litigation that may adversely affect our business or results of operations. We maintain errors and omissions insurance and such other lines of coverage as we believe is reasonable in light of our experience to date. However, this insurance may not be sufficient or available at a reasonable cost to protect us from liabilities that might adversely affect our business or results of operations. Even if any claims brought against us were unsuccessful or without merit, we would still have to defend ourselves against such claims. Any such defenses may be time-consuming and costly, and may distract our management’s attention. As a result, we may incur significant expenses and may be unable to effectively operate our business.

 
Changes in the number of Medicaid eligibles, or benefits provided to Medicaid eligibles or a change in mix of Medicaid eligibles could cause our operating results to suffer.

      Historically, the number of persons eligible to receive Medicaid benefits has increased more rapidly during periods of rising unemployment, corresponding to less favorable general economic conditions. However, during such economic downturns, state budgets could decrease, causing states to attempt to cut health care programs, benefits and rates. If this were to happen while our membership was increasing, our results of operations could suffer. Conversely, the number of persons eligible to receive Medicaid benefits may grow more slowly or even decline if economic conditions improve, thereby causing our operating results to suffer. In either case, in the

44


Table of Contents

event that the company experiences a change in product mix to less profitable product lines, our profitability could be negatively impacted.
 
Changes in SCHIP rules restricting eligibility could cause our operating results to suffer.

      The states in which we operate have experienced budget deficits. In Florida, Texas and Maryland, the rules governing SCHIP have either recently changed, or will likely change in the near future, to restrict or limit eligibility for benefits through the imposition of waiting periods, enrollment caps and/or new or increased co-payments. These changes in SCHIP eligibility could cause us to experience a net loss in SCHIP membership. If the states in which we operate continue to restrict or limit SCHIP eligibility, our operating results could suffer.

 
Our inability to integrate, manage and grow our information systems effectively could disrupt our operations.

      Our operations are significantly dependent on effective information systems. The information gathered and processed by our information systems assists us in, among other things, monitoring utilization and other cost factors, processing provider claims and providing data to our regulators. Our providers also depend upon our information systems for membership verifications, claims status and other information.

      Our information systems and applications require continual maintenance, upgrading and enhancement to meet our operational needs. Moreover, our acquisition activity requires frequent transitions to or from, and the integration of, various information systems. We are continually upgrading and expanding our information systems capabilities. If we experience difficulties with the transition to or from information systems or are unable to properly maintain or expand our information systems, we could suffer, among other things, from operational disruptions, loss of existing members and difficulty in attracting new members, regulatory problems and increases in administrative expenses.

      We estimate that our current claims payment system could be at full capacity within the next 12 months. Accordingly, on November 26, 2003, we announced that we signed a software licensing agreement with The Trizetto Group, Inc. for the Facets Extended EnterpriseTM administrative system. We currently expect that the Facets software will meet our needs for approximately the next ten years and support our long-term growth strategies. We currently estimate implementation of the new system by the end of 2004. However, if we cannot execute a successful system conversion, our operations could be disrupted, which would have a negative impact on our profitability and our ability to grow could be harmed.

 
Acts of terrorism could cause our business to suffer.

      Our profitability depends, to a significant degree, on our ability to predict and effectively manage medical costs. If acts of terrorism were to occur in markets in which we operate, our business could suffer. The results of terrorist acts could lead to higher than expected medical costs, network and information technology disruptions, and other related factors beyond our control, which would cause our business to suffer.

45


Table of Contents

INDEPENDENT AUDITORS’ REPORT

The Board of Directors

AMERIGROUP Corporation and Subsidiaries:

      We have audited the accompanying consolidated balance sheets of AMERIGROUP Corporation and subsidiaries as of December 31, 2003 and 2002, and the related consolidated income statements and statements of stockholders’ equity and cash flows for each of the years in the three-year period ended December 31, 2003. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

      We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

      In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of AMERIGROUP Corporation and subsidiaries as of December 31, 2003 and 2002, and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 2003 in conformity with accounting principles generally accepted in the United States of America.

      As discussed in note 2 to the consolidated financial statements, effective July 1, 2001, AMERIGROUP Corporation adopted the provisions of Statement of Financial Accounting Standards No. 141, Business Combinations, and certain provisions of Statement of Financial Accounting Standards No. 142 (SFAS No. 142), Goodwill and Other Intangible Assets, as required for goodwill and intangible assets arising from business combinations consummated after June 30, 2001. As further discussed in Note 2 to the consolidated financial statements, in 2002, AMERIGROUP Corporation adopted the provisions of SFAS No. 142 as required for goodwill and intangible assets resulting from business combinations consummated prior to June 30, 2001.

February 11, 2004

Norfolk, Virginia

/s/ KPMG LLP

46


Table of Contents

 
Item 8. Financial Statements and Supplementary Data

AMERIGROUP CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

DECEMBER 31, 2003 and 2002
                     
2003 2002


(Dollars in thousands)
ASSETS
Current assets:
               
 
Cash and cash equivalents
  $ 407,220     $ 207,996  
 
Short-term investments
    8,750       27,581  
 
Premium receivables
    38,259       35,233  
 
Deferred income taxes
    10,164       5,627  
 
Prepaid expenses and other current assets
    15,995       7,998  
     
     
 
   
Total current assets
    480,388       284,435  
Property and equipment, net
    31,103       28,277  
Software, net of accumulated amortization of $16,384 and $10,253 at December 31, 2003 and 2002, respectively
    11,055       11,966  
Goodwill and other intangible assets, net of accumulated amortization of $11,722 and $5,873 at December 31, 2003 and 2002, respectively
    144,398       26,040  
Long-term investments
    119,133       71,358  
Investments on deposit for licensure
    35,346       29,559  
Other long-term assets
    4,598       2,716  
Escrow deposit for pending acquisition and related costs
          124,133  
     
     
 
    $ 826,021     $ 578,484  
     
     
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
               
 
Claims payable
  $ 239,532     $ 202,430  
 
Unearned revenue
    54,324       25,518  
 
Accounts payable
    5,523       9,405  
 
Accrued expenses, capital leases and other current liabilities
    53,431       42,905  
     
     
 
   
Total current liabilities
    352,810       280,258  
Long-term debt
          50,000  
Deferred income taxes, capital leases and other long-term liabilities
    11,497       8,845  
     
     
 
   
Total liabilities
    364,307       339,103  
     
     
 
Commitments and contingencies (note 12) 
               
Stockholders’ equity:
               
 
Common stock, $.01 par value. Authorized 100,000,000 shares; issued and outstanding 24,444,622 and 20,551,944 at December 31, 2003 and 2002, respectively
    244       205  
 
Additional paid-in capital
    331,751       177,141  
 
Retained earnings
    129,776       62,452  
 
Deferred compensation
    (57 )     (417 )
     
     
 
   
Total stockholders’ equity
    461,714       239,381  
     
     
 
    $ 826,021     $ 578,484  
     
     
 

See accompanying notes to consolidated financial statements.

47


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

CONSOLIDATED INCOME STATEMENTS

                             
Year Ended December 31,

2003 2002 2001



(Dollars in thousands, except for per share data)
Revenues:
                       
 
Premium
  $ 1,615,508     $ 1,152,636     $ 880,510  
 
Investment income
    6,726       8,026       10,664  
     
     
     
 
   
Total revenues
    1,622,234       1,160,662       891,174  
     
     
     
 
Expenses:
                       
 
Health benefits
    1,295,900       933,591       709,034  
 
Selling, general and administrative
    186,856       133,409       109,822  
 
Depreciation and amortization
    23,650       13,149       9,348  
 
Interest
    1,913       791       763  
     
     
     
 
   
Total expenses
    1,508,319       1,080,940       828,967  
     
     
     
 
   
Income before income taxes
    113,915       79,722       62,207  
Income tax expense
    46,591       32,686       26,127  
     
     
     
 
   
Net income
    67,324       47,036       36,080  
 
Accretion of redeemable preferred stock dividends
                (6,228 )
     
     
     
 
 
Net income attributable to common stockholders
  $ 67,324     $ 47,036     $ 29,852  
     
     
     
 
Net income per share:
                       
 
Basic net income per share
  $ 3.11     $ 2.33     $ 8.08  
     
     
     
 
 
Weighted average number of common shares outstanding
    21,622,704       20,177,728       3,694,844  
     
     
     
 
 
Diluted net income per share
  $ 2.95     $ 2.19     $ 2.08  
     
     
     
 
 
Weighted average number of common shares and dilutive potential common shares outstanding
    22,801,650       21,469,422       16,649,721  
     
     
     
 

See accompanying notes to consolidated financial statements.

48


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

                                                                 
Series D convertible
Common stock preferred stock Additional Retained Total


paid-in earnings Deferred stockholders’
Shares Amount Shares Amount capital (deficit) compensation equity








(Dollars in thousands)
Balances at January 1, 2001
    907,782     $ 9       3,710,775     $ 37     $ 20,270     $ (14,436 )   $ (1,135 )   $ 4,745  
Common stock issued upon exercise of stock options and warrants
    227,205       3                   237                   240  
Common stock issued upon compeletion of initial public offering, net of expenses of $7,577
    4,985,000       50                   77,168                   77,218  
Conversion of convertible preferred stock
    12,607,880       126       (3,710,775 )     (37 )     71,009                   71,098  
Common stock issued upon exercise of Series E mandatorily redeemable preferred stock warrants
    1,123,823       11                   (8 )                 3  
Accreted dividends on redeemable preferred stock
                                  (6,228 )           (6,228 )
Amortization of deferred compensation
                                        360       360  
Net income
                                  36,080             36,080  
     
     
     
     
     
     
     
     
 
Balances at December 31, 2001
    19,851,690       199                   168,676       15,416       (775 )     183,516  
Common stock issued upon exercise of stock options and purchases under the employee stock purchase plan
    700,254       6                   4,690                   4,696  
Tax benefit from exercise of options
                            3,775                   3,775  
Amortization of deferred compensation
                                        358       358  
Net income
                                  47,036             47,036  
     
     
     
     
     
     
     
     
 
Balances at December 31, 2002
    20,551,944       205                   177,141       62,452       (417 )     239,381  
Common stock issued from public offering, net of expenses of $8,226
    3,162,500       32                   138,797                   138,829  
Common stock issued upon exercise of stock options and purchases under the employee stock purchase plan
    730,178       7                   11,266                   11,273  
Tax benefit from exercise of options
                            4,547                   4,547  
Amortization of deferred compensation
                                        360       360  
Net income
                                  67,324             67,324  
     
     
     
     
     
     
     
     
 
Balances at December 31, 2003
    24,444,622     $ 244           $     $ 331,751     $ 129,776     $ (57 )   $ 461,714  
     
     
     
     
     
     
     
     
 

See accompanying notes to consolidated financial statements.

49


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

                                 
Year Ended December 31,

2003 2002 2001



(Dollars in thousands)
Cash flows from operating activities:
                       
 
Net income
  $ 67,324     $ 47,036     $ 36,080  
 
Adjustments to reconcile net income to net cash provided by operating activities:
                       
   
Depreciation and amortization
    23,650       13,149       9,348  
   
Deferred tax (benefit) expense
    (3,272 )     993       (124 )
   
Amortization of deferred compensation
    360       358       360  
   
Tax benefit related to exercise of stock options
    4,547       3,775        
   
Changes in assets and liabilities increasing (decreasing) cash flows from operations:
                       
     
Premium receivables
    (3,026 )     (6,058 )     (13,579 )
     
Prepaid expenses and other current assets
    (7,954 )     (456 )     (254 )
     
Other assets
    (750 )     (1,225 )     744  
     
Claims payable
    16,681       22,084       29,884  
     
Accounts payable, accrued expenses and other, net
    (494 )     12,219       9,934  
     
Unearned revenue
    28,806       25,278       240  
     
Other long-term liabilities
    2,548       704       (150 )
     
     
     
 
       
Net cash provided by operating activities
    128,420       117,857       72,483  
     
     
     
 
Cash flows from investing activities:
                       
 
Proceeds from redemption of held-to-maturity investments
    191,657       219,656       196,267  
 
Purchase of held-to-maturity investments
    (220,601 )     (211,158 )     (257,541 )
 
Purchase of property and equipment and software
    (13,220 )     (20,707 )     (8,608 )
 
Proceeds from redemption of investments on deposit for licensure
    40,009       30,340       29,318  
 
Purchase of investments on deposit for licensure
    (45,496 )     (30,898 )     (34,955 )
 
Purchase of contract rights and related assets
    (8,581 )     (6,633 )     (2,617 )
 
Purchase price adjustment received
    963              
 
Cash acquired through stock acquisition
    27,473              
 
Escrow deposit for pending acquisition and related costs
          (124,133 )      
     
     
     
 
       
Net cash used in investing activities
    (27,796 )     (143,533 )     (78,136 )
     
     
     
 
Cash flows from financing activities:
                       
 
Borrowings under credit facility
          50,000        
 
Net increase (decrease) in bank overdrafts
    4,828       (1,963 )     913  
 
Repayments of borrowings under credit facility
    (50,000 )           (6,177 )
 
Payment of debt issuance costs
    (1,428 )     (440 )     (672 )
 
Payment of capital lease obligations
    (4,902 )     (2,521 )     (1,314 )
 
Proceeds from exercise of common stock options, warrants and employee stock purchases
    11,273       4,696       243  
 
Proceeds from issuance of common stock upon the public offerings, net of issuance costs
    138,829             77,218  
 
Redemption of Series E mandatorily redeemable preferred stock
                (13,320 )
     
     
     
 
       
Net cash provided by financing activities
    98,600       49,772       56,891  
     
     
     
 
Net increase in cash and cash equivalents
    199,224       24,096       51,238  
Cash and cash equivalents at beginning of period
    207,996       183,900       132,662  
     
     
     
 
Cash and cash equivalents at end of period
  $ 407,220     $ 207,996     $ 183,900  
     
     
     
 
Supplemental disclosures of cash flow information:
                       
 
Cash paid for interest
  $ 1,755     $ 767     $ 822  
     
     
     
 
 
Cash paid for income taxes
  $ 40,671     $ 27,795     $ 20,841  
     
     
     
 
Supplemental disclosures of non-cash activities:
                       
 
Property and equipment acquired under capital lease
  $ 5,977     $ 7,775     $ 5,086  
     
     
     
 

      Effective January 1, 2003, we completed our acquisition of PHP Holdings, Inc. and its subsidiary, Physicians Healthcare Plans, Inc. The escrow deposit for pending acquisition and related costs of $124,133 was paid in 2003 and, as a result, we recorded the estimated fair values of the assets acquired and liabilities assumed (see note 5(d)).

See accompanying notes to consolidated financial statements.

50


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2003, 2002 and 2001
(Dollars in thousands, except for per share data)
 
(1) Corporate Organization and Principles of Consolidation
 
(a) Corporate Organization

      AMERIGROUP Corporation, a Delaware corporation (the “Company”), is a multi-state managed health care company focused on serving people who receive health care benefits through public-sponsored programs, including Medicaid, State Children’s Health Insurance Program, or SCHIP, and FamilyCare.

      During 1995, we incorporated wholly owned subsidiaries in New Jersey, Illinois and Texas to develop, own and operate health maintenance organizations (HMOs) in those states. During 1996, we began enrolling Medicaid members in HMOs: AMERIGROUP New Jersey, Inc., AMERIGROUP Illinois, Inc. and AMERIGROUP Texas, Inc. During 1999, we incorporated a wholly owned subsidiary in Delaware, AMERIGROUP Maryland, Inc., a Managed Care Organization, to develop, own and operate a managed care organization (MCO) in Maryland and an HMO in the District of Columbia. Effective January 1, 2003, AMERIGROUP Maryland Inc., a Managed Care Organization, changed its domicile of incorporation to the District of Columbia. During 2001, we incorporated a wholly owned subsidiary in Florida, AMERIGROUP Florida, Inc., an HMO, to develop, own and operate an HMO in Florida. Effective January 1, 2003, AMERIGROUP Corporation acquired PHP Holdings, Inc. and its subsidiary, Physicians Health Plans, Inc. (together, PHP) and merged it with AMERIGROUP Florida, Inc.

      On November 9, 2001, we completed our initial public offering of 4,985,000 shares of common stock, including an over-allotment issuance of 585,000 shares at a price per share of $17.00. We received net proceeds from the offering of $77,218. In conjunction with the offering, all Series A, B, C and D preferred stock in the aggregate was converted into 12,607,880 shares of common stock. The proceeds from the offering were used to repay the balance of our long-term debt facility of $4,352 and to redeem the Series E mandatorily redeemable preferred stock for $13,320. In addition, 1,123,823 shares of common stock were issued upon the exercise of all outstanding Series E warrants.

      On October 16, 2003, we completed a public offering of 3,162,500 shares of common stock, including an over-allotment issuance of 412,500 shares at a price of $46.50 per share. We received net proceeds from the offering of $138,830. On October 21, 2003, we used $30,000 of proceeds from the offering to repay the outstanding balance of our credit facility.

 
     (b)  Principles of Consolidation

      The consolidated financial statements include the financial statements of AMERIGROUP Corporation and our five wholly owned subsidiaries: AMERIGROUP New Jersey, Inc., AMERIGROUP Illinois, Inc., AMERIGROUP Texas, Inc. and AMERIGROUP Florida, Inc., each a Health Maintenance Organization; AMERIGROUP Maryland, Inc., a Managed Care Organization and PHP Holdings, Inc., a holding company that is the parent company of AMERIGROUP Florida, Inc. All significant intercompany balances and transactions have been eliminated in consolidation.

 
(2) Summary of Significant Accounting Policies and Practices
 
(a) Cash Equivalents

      We consider all highly liquid temporary investments with original maturities of three months or less to be cash equivalents. We had cash equivalents of $323,190 and $107,978 at December 31, 2003 and 2002, respectively, which consist of money market funds, U.S. Treasury securities, certificates of deposit, asset-backed securities, auction rate securities and debt securities of government sponsored entities.

51


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
     (b)  Short and Long-Term Investments and Investments on Deposit for Licensure

      Short and long-term investments and investments on deposit for licensure at December 31, 2003 and 2002 consist of money market funds, U.S. Treasury securities, cash escrow accounts, asset-backed securities, debt securities of government sponsored entities, municipal bonds and auction rate securities. We consider all investments with original maturities greater than three months but less than twelve months to be short-term investments. We classify our debt and equity securities in one of three categories: trading, available-for-sale or held-to-maturity. Trading securities are bought and held principally for the purpose of selling them in the near term. Held-to-maturity securities are those securities in which we have the ability and intent to hold the security until maturity. All other securities not included in trading or held-to-maturity are classified as available-for-sale. At December 31, 2003 and 2002, all of our securities are classified as held-to-maturity.

      Held-to-maturity securities are recorded at amortized cost, adjusted for the amortization or accretion of premiums or discounts. A decline in the market value of any held-to-maturity security below cost that is deemed other than temporary results in a reduction in carrying amount to fair value. The impairment is charged to earnings and a new cost basis for the security is established. Premiums and discounts are amortized or accreted over the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Dividend and interest income is recognized when earned.

 
     (c)  Property and Equipment

      Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation on property and equipment is calculated on the straight-line method over the estimated useful lives of the assets. Property and equipment held under leasehold improvements are amortized on the straight-line method over the shorter of the lease term or estimated useful life of the asset. The estimated useful lives are as follows:

         
Leasehold improvements
    Length of lease  
Furniture and fixtures
    5-7 years  
Equipment
    3-5 years  
 
     (d)  Software

      Software is stated at cost less accumulated amortization, and in accordance with Statement of Position 98-1, Accounting for the Costs of Software Developed or Obtained for Internal Use. Software is amortized over its estimated useful life of three years, using the straight-line method.

 
     (e) Goodwill and Other Intangibles

      Goodwill represents the excess of aggregate purchase price over the estimated fair value of net assets acquired. Goodwill acquired prior to July 1, 2001, was amortized on a straight-line basis over 18 months to 20 years, the expected periods to be benefited. In accordance with Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible Assets (SFAS No. 142), goodwill acquired subsequent to July 1, 2001 is not amortized but instead is tested for impairment at least annually. In addition, all goodwill acquired prior to July 2001 is no longer amortized effective January 1, 2002 but instead is tested for impairment at least annually. SFAS No. 142 also requires that intangible assets with estimable useful lives be amortized over their respective estimated useful lives to their estimated residual values, and reviewed for impairment in accordance with Statement of Financial Accounting Standards No. 144, Accounting for Impairment or Disposal of Long-Lived Assets.

52


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      The following table presents net income and net income per share exclusive of goodwill amortization expense for 2003, 2002 and 2001.

                           
2003 2002 2001



Net income:
                       
 
Reported net income
  $ 67,324     $ 47,036     $ 36,080  
 
Goodwill amortization, net of tax effect
                567  
     
     
     
 
 
Adjusted net income
  $ 67,324     $ 47,036     $ 36,647  
     
     
     
 
Basic net income per share:
                       
 
Reported basic net income per share
  $ 3.11     $ 2.33     $ 8.08  
 
Goodwill amortization per basic share
                0.15  
     
     
     
 
 
Adjusted basic net income per share
  $ 3.11     $ 2.33     $ 8.23  
     
     
     
 
Diluted net income per share:
                       
 
Reported diluted net income per share
  $ 2.95     $ 2.19     $ 2.08  
 
Goodwill amortization per diluted share
                0.03  
     
     
     
 
 
Adjusted diluted net income per share
  $ 2.95     $ 2.19     $ 2.11  
     
     
     
 
 
     (f)  Other Assets

      Other assets include deposits, debt issuance costs and cash surrender value of life insurance policies.

 
     (g)  Income Taxes

      Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 
     (h)  Stock-Based Compensation

      As permitted under Statement of Financial Accounting Standards No. 123, Accounting for Stock-Based Compensation (SFAS No. 123), we have chosen to account for stock-based compensation using the intrinsic value method prescribed in Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees (APB Opinion No. 25), and related interpretations. Accordingly, compensation cost for stock options is measured as the excess, if any, of the estimated fair value of our stock at the date of grant over the amount an employee must pay to acquire the stock. In December 2002, Statement of Financial Accounting Standards No. 148, Stock-Based Compensation (SFAS No. 148), was issued which requires that we illustrate the effect on net income and net income per share if we had applied the fair value principles included in SFAS No. 123 for

53


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

both annual and interim financial statements. The following table illustrates the effect on net income and earnings per share if the company had applied the fair value recognition.

                           
2003 2002 2001



Net income:
                       
 
Reported net income
  $ 67,324     $ 47,036     $ 36,080  
 
Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects
    9,577       5,800       807  
     
     
     
 
 
Proforma net income
  $ 57,747     $ 41,236     $ 35,273  
     
     
     
 
Basic net income per share:
                       
 
Reported basic net income per share
  $ 3.11     $ 2.33     $ 8.08  
 
Proforma basic net income per share
    2.67       2.04       7.86  
Diluted net income per share:
                       
 
Reported diluted net income per share
  $ 2.95     $ 2.19     $ 2.08  
 
Proforma diluted net income per share
    2.56       1.92       2.04  
 
     (i)  Premium Revenue

      We record premium revenue based on membership and premium information from each state. Premiums are due monthly and are recognized as revenue during the period in which we are obligated to provide service to members. In all of our markets, except Florida, we receive payments under each state’s obstetric delivery supplements program. Upon delivery of a newborn, each state is notified according to our contract. We recognize revenue in the period that the newborn is delivered and related services were provided to our member. Additionally, in some states we receive supplemental payments for certain services such as high cost drugs and early childhood prevention screenings. Any amounts that have not been received from the state by the end of the period are recorded on our balance sheet as premium receivables.

 
     (j)  Experience Rebate Payable

      Experience rebate payable, included in accrued expenses, capital leases and other current liabilities, consists of estimates of amounts due under contracts with a state government. These amounts are computed based on a percentage of the contract profits, as defined, in the contract with the state. The profitability computation includes premium revenue received from the state less actual medical and administrative costs incurred and paid and less estimated unpaid claims payable for the applicable membership. The unpaid claims payable estimates are based on historical payment patterns using actuarial techniques. A final settlement is generally made 334 days after the contract period ends using paid claims data. Any adjustment made to the experience rebate payable as a result of final settlement is included in current operations.

 
     (k)  Claims Payable

      Accrued medical expenses for inpatient, outpatient surgery, emergency room, specialist, pharmacy and ancillary medical claims include amounts billed and not paid and an estimate of cost incurred for unbilled services provided. These liabilities are principally based on historical payment patterns using actuarial techniques. In addition, claims processing costs are accrued based on an estimate of the costs necessary to process unpaid claims. Claims payable are reviewed and adjusted periodically and, as adjustments are made, differences are included in current operations. Claims payable also includes estimates of amounts due to or from contracted providers under risk-sharing arrangements. The arrangements are typically based upon quality measures as well as medical results. Estimates relating to risk-sharing arrangements are calculated as a

54


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

percentage, typically 25% to 50%, of the differences between actual results and specified targets of medical expense and may include a sharing of profits in excess of the targeted medical and administrative expenses, typically 7% to 10% of total premiums covered under the contract.

 
     (l)  Stop-loss Coverage

      Stop-loss premiums, net of recoveries, are included in health benefits expense in the accompanying Consolidated Income Statements.

 
     (m)  Impairment of Long-Lived Assets

      We adopted SFAS No. 144 on January 1, 2002. The adoption of SFAS No. 144 did not affect our financial statements.

      In accordance with SFAS No. 144, long-lived assets, such as property and equipment and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of would be separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell, and are no longer depreciated. The assets and liabilities of a group classified as held for sale would be presented separately in the appropriate asset and liability sections of the balance sheet. No impairment of long-lived assets was recorded in 2003, 2002 or 2001.

      Goodwill is tested annually for impairment, and is tested for impairment more frequently if events and circumstances indicate that the asset might be impaired. An impairment loss is recognized to the extent that the carrying amount exceeds the asset’s fair value. This determination is made at the reporting unit level and consists of two steps. First, we determine the fair value of a reporting unit and compare it to its carrying amount. Second, if the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recognized for any excess of the carrying amount of the reporting unit’s goodwill over the implied fair value of that goodwill. The implied fair value of goodwill is determined by allocating the fair value of the reporting unit in a manner similar to a purchase price allocation, in accordance with SFAS No. 141. The residual fair value after this allocation is the implied fair value of the reporting unit goodwill. No impairment of goodwill was recorded in 2003, 2002 or 2001.

 
     (n)  Net Income Per Share

      Basic net income per share has been computed by dividing net income attributable to common stockholders by the weighted average number of common shares outstanding. Diluted net income per share reflects the potential dilution that could occur assuming the inclusion of dilutive potential common shares and has been computed by dividing net income attributable to common stockholders by the weighted average number of common shares and dilutive potential common shares outstanding. Dilutive potential common shares include all outstanding stock options and warrants after applying the treasury stock method and convertible redeemable preferred stock to the extent it is dilutive.

 
     (o)  Use of Estimates

      Our management has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period to prepare these consolidated financial statements in conformity with generally accepted accounting principles. Actual results could differ from those estimates.

55


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
     (p)  Reclassifications

      Certain reclassifications have been made to prior year amounts to conform to the current year presentation.

 
     (q)  Risks and Uncertainties

      Our profitability depends in large part on accurately predicting and effectively managing health benefits expense. We continually review our premium and benefit structure to reflect its underlying claims experience and revised actuarial data; however, several factors could adversely affect the health benefits expense. Certain of these factors, which include changes in health care practices, inflation, new technologies, major epidemics, natural disasters and malpractice litigation, are beyond any health plan’s control and could adversely affect our ability to accurately predict and effectively control health care costs. Costs in excess of those anticipated could have a material adverse effect on our results of operations.

      At December 31, 2003, we served members who received health care benefits through nine contracts with the regulatory entities in the jurisdictions in which we operate. Five of these contracts individually accounted for 10% or more of our revenues for the year ended December 31, 2003, with the largest of these contracts representing approximately 20% of our revenues.

 
(3) Short and Long-Term Investments and Investments on Deposit for Licensure

      The amortized cost, gross unrealized holding gains, gross unrealized holding losses and fair value for held-to-maturity short-term investments are as follows at December 31, 2003 and 2002:

                                     
Gross Gross
unrealized unrealized
Amortized holding holding Fair
cost gains losses value




2003:
                               
 
Commercial paper
  $ 1,000     $     $     $ 1,000  
 
Auction rate securities
    6,500                   6,500  
 
Debt securities of government sponsored entities
    1,250                   1,250  
     
     
     
     
 
   
Total
  $ 8,750     $     $     $ 8,750  
     
     
     
     
 
2002:
                               
 
Money market funds
  $ 8,000     $     $     $ 8,000  
 
Asset-backed securities
    7,306       1             7,307  
 
Debt securities of government sponsored entities
    12,275       6             12,281  
     
     
     
     
 
   
Total
  $ 27,581     $ 7     $     $ 27,588  
     
     
     
     
 

56


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      The amortized cost, gross unrealized holding gains, gross unrealized holding losses and fair value for held-to-maturity long-term investments are as follows at December 31, 2003 and 2002:

                             
Gross Gross
unrealized unrealized
Amortized holding holding
cost gains losses



2003:
                       
 
Municipal bonds
  $ 7,115     $ 3     $  
 
Debt securities of government sponsored entities, maturing within one year
    1,500       1        
 
Debt securities of government sponsored entities, maturing between one year and five years
    103,215       146       96  
 
Auction rate securities
    7,303             3  
     
     
     
 
   
Total
  $ 119,133     $ 150     $ 99  
     
     
     
 
2002:
                       
 
Municipal bonds
  $ 13,402     $ 31     $  
 
Debt securities of government sponsored entities, maturing
    55,956       312        
 
within one year Auction rate securities
    2,000              
     
     
     
 
   
Total
  $ 71,358     $ 343     $  
     
     
     
 

      As a condition for licensure by various state governments to operate HMOs or MCOs, we are required to maintain certain funds on deposit with or under the control of the various departments of insurance. Accordingly, at December 31, 2003 and 2002, the amortized cost, gross unrealized holding gains, gross unrealized holding losses and fair value for these held-to-maturity securities are summarized as follows:

                                     
Gross Gross
unrealized unrealized
Amortized holding holding Fair
cost gains losses value




2003:
                               
 
Money market funds
  $ 4,718     $     $     $ 4,718  
 
U.S. Treasury securities, maturing within one year
    5,543       18             5,561  
 
U.S. Treasury securities, maturing between one year and five years
    407       1             408  
 
Debt securities of government sponsored entities, maturing between one year and five years
    22,432       61       4       22,489  
 
Cash escrow account
    2,246                   2,246  
     
     
     
     
 
   
Total
  $ 35,346     $ 80     $ 4     $ 35,422  
     
     
     
     
 
2002:
                               
 
U.S. Treasury securities, maturing within one year
  $ 1,203     $     $     $ 1,203  
 
U.S. Treasury securities, maturing between one year and five years
    5,543             54       5,489  
 
Debt securities of government sponsored entities, maturing within one year
    22,003       152             22,155  
 
Cash escrow account
    810                   810  
     
     
     
     
 
   
Total
  $ 29,559     $ 152     $ 54     $ 29,657  
     
     
     
     
 

57


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      The state governments in which we operate require us to maintain investments on deposit in specific dollar amounts based on either formulas or set amounts as determined by state regulations. We purchase interest-based investments with a fair value equal to or greater than the required dollar amount. The interest that accrues on these investments is not restricted and is available for withdrawal.

      The following table summarizes our held-to-maturity investments with gross unrealized holding losses at December 31, 2003.

                   
Gross
unrealized
Fair holding
Description of Securities value losses



Auction rate securities
  $ 800     $ 3  
Debt securities of government sponsored entities
    26,283       100  
     
     
 
 
Total temporarily impaired securities
  $ 27,083     $ 103  
     
     
 

      One auction rate security and thirteen debt securities of government sponsored entities had temporary declines in value as of December 31, 2003. All temporary declines in value of held-to-maturity investments have experienced declines in value for less than twelve months. The temporary declines in value are primarily due to fluctuations in market interest rates.

 
(4) Property and Equipment, Net

      Property and equipment, net at December 31, 2003 and 2002 is summarized as follows:

                 
2003 2002


Leasehold improvements
  $ 11,096     $ 7,427  
Furniture and fixtures
    6,669       6,709  
Equipment
    41,341       31,068  
     
     
 
      59,106       45,204  
Less accumulated depreciation and amortization
    (28,003 )     (16,927 )
     
     
 
    $ 31,103     $ 28,277  
     
     
 
 
(5) Acquisitions
 
(a) Humana

      Effective August 1, 2001, we purchased certain assets of Humana Inc.’s (Humana) Houston, Texas Medicaid line of business. The assets purchased consisted of Humana’s rights to provide managed care services to its Medicaid members. We utilized the purchase method of accounting. We paid $1,048 in cash including transaction costs, resulting in goodwill of the same amount. We operated as a Medicaid HMO in Houston, Texas prior to this acquisition.

 
     (b)  MethodistCare

      Effective January 1, 2002, we purchased certain assets of MethodistCare, Inc.’s (MethodistCare) Houston, Texas Medicaid line of business. The assets purchased consisted of MethodistCare’s rights to provide managed care services to its Medicaid members. We paid $1,232 in cash including transaction costs, resulting in goodwill of the same amount.

58


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
     (c)  Capital Community Health Plan

      Effective July 1, 2002, we purchased the Medicaid contracts and related assets of Capital Community Health Plan, or CCHP, in Washington, D.C. for $6,970, including acquisition costs. The assets purchased consisted primarily of CCHP’s rights to provide managed care services to its Medicaid members. During 2003, we settled on the final purchase price as provided under the asset purchase agreement and reduced goodwill by $963. Goodwill and other intangibles totaling $6,007 included $423 for identifiable intangibles allocated to the membership purchased. Identifiable intangibles with definite useful lives are being amortized based on the timing of related cash flows over eight years.

 
     (d)  Physicians Healthcare Plans, Inc.

      Effective January 1, 2003, we completed our acquisition of PHP Holdings, Inc. and its subsidiary, Physicians Healthcare Plans, Inc. (together, PHP) pursuant to the terms of a merger agreement entered into on August 22, 2002 for $124,260, including acquisition costs of $1,260.

      Established in 1992, PHP served 193,000 Medicaid and State Children’s Health Insurance Program (SCHIP) members at December 31, 2002 in twelve counties including the metropolitan areas of Orlando, Tampa and Ft. Lauderdale/Miami. PHP also served Medicare and commercial members which were spun off from PHP prior to December 31, 2002 and not acquired by us.

      Of the $124,260 acquisition cost which includes transaction costs, approximately $50,000 was financed through our then-existing credit facility with the balance funded through unregulated cash. Goodwill and other intangibles totaling $116,587 includes $8,990 of identifiable intangibles allocated to the rights to membership and a non-compete agreement. Intangible assets related to the non-compete agreement and rights to membership are being amortized based on the timing of related cash flows with an expected amortization of five to eleven years. A portion of the purchase price remains in escrow pending various settlement provisions between us and the former shareholders of PHP Holdings, Inc. Purchase price adjustments may arise in the future as a result of these settlements.

      The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition.

           
Current assets, including cash and cash equivalents
  $ 31,668  
Intangible assets
    8,990  
Goodwill
    107,597  
Other assets
    2,482  
     
 
 
Total assets acquired
    150,737  
Claims payable
    20,421  
Other liabilities
    6,056  
     
 
 
Total liabilities assumed
    26,477  
     
 
 
Net assets acquired
  $ 124,260  
     
 

      The following unaudited pro forma summary information presents the consolidated income statement information for the twelve month period ended December 31, 2002 as if the PHP transaction had been

59


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

consummated on January 1, 2002, and does not purport to be indicative of what would have occurred had the acquisition been made at that date or of the results which may occur in the future.

         
Premium revenue
  $ 1,412,916  
     
 
Net income
  $ 55,035  
     
 
Diluted net income per share
  $ 2.56  
     
 

      The unaudited pro forma summary information reflects adjustments made to our historical financial statements by including the applicable results of operations of PHP’s Medicaid and SCHIP lines of business in Florida prior to the acquisition.

 
     (e)  St. Augustine, AvMed, Inc.

      Effective July 1, 2003, we purchased the Medicaid contracts and related assets known as St. Augustine for $8,581. The assets purchased consisted primarily of St. Augustine’s rights to provide managed care services to its 26,000 Medicaid members who receive health care benefits under Florida’s Medicaid program in nine counties in the Miami/ Ft. Lauderdale, Orlando and Tampa markets. Goodwill and other intangibles totaling $8,581 includes $2,151 for identifiable intangibles allocated to a non-compete agreement and the rights to the membership. Intangible assets related to the non-compete agreement and the rights to the membership are being amortized based on the timing of related cash flows with an expected amortization of three to eight years.

 
(6) Income Taxes

      Income tax expense (benefit) for the years ended December 31, 2003, 2002 and 2001 consists of the following:

                           
Current Deferred Total



Year ended December 31, 2003:
                       
 
U.S. federal
  $ 42,238     $ (2,409 )   $ 39,829  
 
State and local
    7,625       (863 )     6,762  
     
     
     
 
    $ 49,863     $ (3,272 )   $ 46,591  
     
     
     
 
Year ended December 31, 2002:
                       
 
U.S. federal
  $ 25,798     $ 854     $ 26,652  
 
State and local
    5,895       139       6,034  
     
     
     
 
    $ 31,693     $ 993     $ 32,686  
     
     
     
 
Year ended December 31, 2001:
                       
 
U.S. federal
  $ 22,685     $ (222 )   $ 22,463  
 
State and local
    3,566       98       3,664  
     
     
     
 
    $ 26,251     $ (124 )   $ 26,127  
     
     
     
 

60


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      Income tax expense differed from the amounts computed by applying the U.S. federal income tax rate to income before income taxes as a result of the following:

                                                     
Years ended December 31,

2003 2002 2001



Amount % Amount % Amount %






Tax expense at statutory rate
  $ 39,870       35.0 %   $ 27,902       35.0 %   $ 21,772       35.0 %
Increase in income taxes resulting from:
                                               
 
State and local income taxes, net of federal income tax effect
    4,395       3.9       3,922       4.9       2,382       3.8  
 
Effect of nondeductible expenses and other, net
    2,326       2.0       862       1.1       1,973       3.2  
     
     
     
     
     
     
 
   
Total income tax expense
  $ 46,591       40.9 %   $ 32,686       41.0 %   $ 26,127       42.0 %
     
     
     
     
     
     
 

      The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities at December 31, 2003 and 2002 are presented below:

                     
December 31,

2003 2002


Deferred tax assets:
               
 
Estimated claims incurred but not reported, a portion of which is deductible as paid for tax purposes
  $ 2,338     $ 2,238  
 
Vacation, bonus and other accruals, deductible as paid for tax purposes
    5,844       2,529  
 
Contractual allowances, deductible as written off for tax purposes
    762       1,235  
 
Other expenses, deductible in future periods for tax purposes
    1,563       859  
 
Goodwill, due to timing differences in book and tax amortization
    209       117  
 
Unearned revenue, included in income as received for tax purposes
    4,330       1,965  
 
State net operating loss/credit carryforwards, deductible in future periods for tax purposes
    1,780       785  
     
     
 
   
Gross deferred tax assets before valuation allowance
    16,826       9,728  
Less: Valuation allowance
          (785 )
     
     
 
 
Net deferred tax assets
    16,826       8,943  
Deferred tax liabilities:
               
 
Property and equipment, due to timing differences in book and tax depreciation
    (5,271 )     (3,659 )
 
Deductible prepaid expenses and other
    (2,293 )     (2,064 )
     
     
 
   
Gross deferred tax liabilities
    (7,564 )     (5,723 )
     
     
 
   
Net deferred tax asset
  $ 9,262     $ 3,220  
     
     
 

      The valuation allowance for deferred tax assets decreased by $785 in 2003 which decreased income tax expense by the same amount. The decrease in this allowance was due to the utilization of a state tax credit carryforward that we had previously established a valuation allowance for in 2002. The increase in the valuation allowance of $785 in 2002 increased income tax by the same amount. The allowance was established in 2002 as the state tax credit carryforward was only available for use to the extent our regular tax liability exceeded the alternative minimum tax liability for a given year. Future projections in 2002 did not show the regular tax liability exceeding the alternative minimum tax; however, the credit was utilized in 2003. In assessing the realizability of

61


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

deferred tax assets, we consider whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. We consider the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. In order to fully realize the deferred tax asset, we will need to generate future taxable income of $1,780 prior to the expiration of a state net operating loss carryforward in 2022 and 2023. Based upon the level of historical taxable income and projections for future taxable income over the periods in which the deferred tax assets are deductible, we believe it is more likely than not that we will realize the benefits of those deductible differences at December 31, 2003. The amount of the deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income during the carryforward period are reduced.

      Income taxes payable were $7,005 and $2,360 at December 31, 2003 and 2002 and were included in accrued expenses, capital leases and other current liabilities.

 
(7) Long-Term Debt

      On October 22, 2003, we entered into a $95,000 Amended and Restated Credit Agreement (Credit Agreement) with a syndicate of banks. The Credit Agreement contains a provision which allows us to obtain, subject to certain conditions, an increase in revolving commitments of up to an additional $30,000. The proceeds of the Credit Agreement are available for general corporate purposes, including, without limitation, permitted acquisitions of businesses, assets and technologies. The borrowings under the Credit Agreement will accrue interest at one of the following rates, at our option: Eurodollar plus the applicable margin or an alternate base rate plus the applicable margin. The applicable margin for Eurodollar borrowings is between 2.00% and 2.50% and the applicable margin for alternate base rate borrowings is between 1.00% and 1.50%. The applicable margin will vary depending on our leverage ratio. The Credit Agreement is secured by substantially all of the assets of AMERIGROUP Corporation and its wholly owned subsidiary, PHP Holdings, Inc., including the stock of their respective wholly owned managed care subsidiaries. There is a commitment fee on the unused portion of the Credit Agreement that ranges from 0.375% to 0.50%, depending on the leverage ratio. The Credit Agreement terminates on October 22, 2006 and was undrawn as of December 31, 2003.

      During 2001, we entered into a Credit and Guaranty Agreement with a syndicate of banks to obtain a $60,000 revolving credit facility. In July 2002, we expanded the facility to include an additional bank and to increase the revolving credit facility to $75,000. The facility was secured by the assets of AMERIGROUP Corporation and by the common stock of its direct, wholly owned subsidiaries. At December 31, 2002, $50,000 was outstanding under the facility. Amounts outstanding under the facility accrued interest at one of the following rates, at our option: LIBOR plus the applicable margin or an alternate bank rate plus the applicable margin. The applicable margin for LIBOR borrowings was between 2.0% and 2.5%. The applicable margin for alternate bank rate borrowings was between 1.0% and 1.5%. The applicable margin varied depending on our leverage ratio. We also paid a 0.50% commitment fee on the unused portion of the facility. This credit facility was repaid during 2003 and replaced with the Credit Agreement.

      Pursuant to the Credit Agreement, we must meet certain financial covenants. These financial covenants include meeting certain financial ratios, a limit on annual capital expenditures, and a minimum net worth requirement.

62


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
(8) Redeemable Preferred Stock

      Redeemable preferred stock is summarized as follows:

                                                                 
Series A Series B Series C Series E




Shares Amount Shares Amount Shares Amount Shares Amount








Balances at January 1, 2001
    8,000,000     $ 15,464       7,025,000     $ 25,324       6,480,000     $ 25,528       2,000,000     $ 11,874  
Accreted dividends
          1,058             1,792             1,932             1,446  
Conversion of Series A, B and C preferred stock to common shares
    (8,000,000 )     (16,522 )     (7,025,000 )     (27,116 )     (6,480,000 )     (27,460 )            
Redemption of Series E mandatorily redeemable preferred stock
                                        (2,000,000 )     (13,320 )
     
     
     
     
     
     
     
     
 
Balances at December 31, 2001
        $           $           $           $  
     
     
     
     
     
     
     
     
 
 
Series A, B and C

      The Series A, B and C preferred stock were convertible to common shares on a two-for-one basis, at the option of the preferred stockholder. The Series A, B and C preferred stock carried a noncumulative 10% dividend payable upon approval by the Board of Directors. We accreted dividends on Series A, B and C using the interest method and added the accrued dividends to the applicable redeemable preferred stock issue balance.

      The Series A, B and C preferred stock was converted into 10,752,493 shares of common stock concurrent with our initial public offering.

 
Series E

      During July 1998, we issued 1,000,000 units of its Series E Mandatorily Redeemable Preferred Stock and Warrants (Series E) at a price of $5.00 per unit (the first tranche). During January 1999, we issued an additional 1,000,000 units of the Series E at a price of $5.00 per unit (the second tranche). Each unit included a share of Series E preferred stock and an unattached warrant to purchase 0.5625 shares of common stock at a price of $0.02 per share. Of the gross proceeds of $5.00, $0.80 has been allocated to the warrants issued based on fair value. The fair value of the warrants sold was determined by our Board of Directors and was consistent with the exercise price of our stock options at the time of issuance. Concurrent with the offering, the warrants were exercised for 1,123,823 shares of common stock. The remaining amount of $4.20 is attributable to Series E stock. The redeemable preferred stock was recorded at its original fair value of $4.20 per share, plus accreted dividends.

63


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

In accordance with the terms of the Series E mandatorily redeemable preferred stock, dividends per share accrued as follows:

                 
First Tranche Second Tranche


September 30, 1998
  $ 2.05     $  
December 31, 1998
           
March 31, 1999
          2.05  
June 30, 1999
           
September 30, 1999
           
December 31, 1999
           
March 31, 2000
           
June 30, 2000
           
September 30, 2000
           
December 31, 2000
    0.10        
March 31, 2001
    0.15        
June 30, 2001
    0.16       0.10  
September 30, 2001
    0.16       0.15  

      The total of these dividends was charged to retained earnings on the interest method.

      The Series E stock, with cumulative dividends, was redeemed concurrent with our initial public offering.

 
(9) Stock Option Plan

      In May 2003, our shareholders approved and we adopted the 2003 Equity Incentive Plan (2003 Plan), which provides for the granting of stock options, restricted stock, phantom stock and stock bonuses to employees, directors and consultants. We reserved for issuance a maximum of 1,650,000 shares of common stock under the 2003 Plan. In addition, shares remaining available for issuance under our 2000 Stock Plan (described below) and our 1994 Stock Plan (described below) will be available for issuance under the 2003 Plan. Under all plans, an option’s maximum term is ten years. As of December 31, 2003, we had a total of 1,311,878 options available for issuance under our 2003 Plan, 2000 Plan and 1994 Plan.

      In July 2000, we adopted the 2000 Equity Incentive Plan (2000 Plan), which provides for the granting of stock options, restricted stock, phantom stock and stock bonuses to employees, directors and consultants. We reserved for issuance a maximum of 2,064,000 shares of common stock under the 2000 Plan at inception. In addition, shares remaining available for issuance under our 1994 Stock Plan (described below) were available for issuance under the 2000 Plan. Twenty percent of the options vest upon grant date or at an employee’s hiring anniversary date, whichever is later, and five percent at the end of each three-month period thereafter.

      In 1994, we established the 1994 Stock Plan (1994 Plan), which provides for the granting of either incentive stock options or nonqualified options to purchase shares of our common stock by employees, directors and consultants of the Company for up to 2,099,500 shares of common stock as of December 31, 1999. On February 9, 2000, we increased the number of options available for grant to 2,249,500.

64


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      A summary of stock plans at December 31, 2003, 2002, and 2001 and the changes during the years then ended follows:

                                                 
2003 2002 2001



Weighted- Weighted- Weighted-
average average average
exercise exercise exercise
Shares price Shares price Shares price






Outstanding at beginning of year
    2,414,934     $ 14.39       2,074,734     $ 7.92       1,776,029     $ 4.61  
Granted
    1,148,673       30.85       1,077,893       22.12       637,366       15.45  
Exercised
    695,139       14.78       647,548       5.87       218,428       1.61  
Forfeited
    185,736       20.52       90,145       19.07       120,233       10.25  
     
             
             
         
Outstanding at end of year
    2,682,732     $ 20.93       2,414,934     $ 14.39       2,074,734     $ 7.92  
     
     
     
     
     
     
 

      The following table summarizes information related to the stock options outstanding at December 31, 2003:

                                         
Weighted-
average
remaining Weighted- Weighted-
Options contractual average Options average
Range of exercise prices outstanding life (years) exercise price exercisable exercise price






$0.00 — $4.54
    366,398       2.7     $ 1.00       357,153     $ 0.95  
$4.55 — $9.07
    102,122       5.7     $ 8.60       90,215     $ 8.60  
$9.08 — $13.60
    5,550       6.2     $ 11.78       3,087     $ 11.73  
$13.61 — $18.14
    502,167       7.0     $ 15.43       269,509     $ 15.25  
$18.15 — $22.67
    553,078       7.8     $ 21.25       251,855     $ 21.25  
$22.68 — $27.21
    649,417       8.4     $ 26.50       292,936     $ 26.46  
$27.22 — $31.75
    300,000       9.4     $ 31.26           $  
$31.76 — $36.28
    3,000       0.2     $ 33.55       3,000     $ 33.55  
$36.29 — $40.81
              $           $  
$40.82 — $45.35
    201,000       8.3     $ 43.03       7,812     $ 43.32  
     
                     
         
      2,682,732       7.2     $ 20.93       1,275,567     $ 14.74  
     
     
     
     
     
 

      On February 11, 2004, we granted an additional 539,729 options at an exercise price of $37.07.

      We apply APB Opinion No. 25 and related interpretations in accounting for our stock plans. Accordingly, compensation cost related to stock options issued to employees would be recorded on the date of grant only if the current market price of the underlying stock exceeded the exercise price. During 2000, we recorded deferred charges of $1,833, representing the difference between the exercise price and the deemed fair value of our common stock for the options granted in 2000. The deferred compensation is being amortized to expense over the period the options vest, generally four to five years. We recognized $360, $358 and $360 in non-cash compensation expense related to the amortization of deferred compensation during 2003, 2002 and 2001, respectively.

      The fair value of each option grant is estimated on the date of grant using an option pricing model with the following assumptions: no dividend yield for all years, risk-free interest rate of 3.2%, 3.6% and 4.3%, expected life of 6.7, 4.0 and 3.5 years and volatility of 44.6%, 49.7% and 0.0%, for the years ended December 31, 2003, 2002 and 2001, respectively. Volatility is estimated to be zero in 2001 because our common stock was not publicly traded until November 6, 2001.

65


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
(10) Earnings Per Share

      The following table sets forth the calculation of basic and diluted net income per share:

                           
Year ended December 31,

2003 2002 2001



Basic net income per share:
                       
 
Net income
  $ 67,324     $ 47,036     $ 36,080  
 
Less: Accretion of convertible redeemable preferred stock dividends
                (6,228 )
     
     
     
 
 
Net income attributable to common stockholders
  $ 67,324     $ 47,036     $ 29,852  
     
     
     
 
 
Weighted average number of common shares outstanding
    21,622,704       20,177,728       3,694,844  
     
     
     
 
 
Basic net income per share
  $ 3.11     $ 2.33     $ 8.08  
     
     
     
 
Diluted net income per share:
                       
 
Net income attributable to common stockholders
  $ 67,324     $ 47,036     $ 29,852  
 
Plus: Accretion of convertible preferred stock dividends assuming conversion
                4,782  
     
     
     
 
 
Diluted net income attributable to common stockholders
  $ 67,324     $ 47,036     $ 34,634  
     
     
     
 
 
Weighted average number of common shares outstanding
    21,622,704       20,177,728       3,694,844  
 
Dilutive effect of stock options and warrants (as determined by applying the treasury stock method) and convertible preferred stock
    1,178,946       1,291,694       12,954,877  
     
     
     
 
 
Weighted average number of common shares and dilutive potential common shares outstanding
    22,801,650       21,469,422       16,649,721  
     
     
     
 
 
Diluted net income per share
  $ 2.95     $ 2.19     $ 2.08  
     
     
     
 
 
(11) Fair Value of Financial Instruments

      The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties. The following methods and assumptions were used to estimate the fair value of each class of financial instruments:

      Cash and cash equivalents, premium receivables, prepaid expenses and other current assets, accounts payable, unearned revenue, accrued expenses and other current liabilities and claims payable: The carrying amounts approximate fair value because of the short maturity of these items.

      Short-term investments, long-term investments and investments on deposit for licensure: The carrying amounts approximate their fair values, which were determined based upon quoted market prices (note 3).

      Long-term debt: The carrying amount of long-term debt approximates fair value as the interest rate of the outstanding debt fluctuates with market interest rates.

66


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
(12) Commitments and Contingencies
 
(a) Minimum Reserve Requirements

      Regulations governing our managed care operations in New Jersey, Texas, Illinois, Maryland, Florida and the District of Columbia require the applicable subsidiary to meet certain minimum net worth requirements. Each subsidiary was in compliance with its requirements at December 31, 2003.

 
     (b)  Malpractice

      We maintain professional liability coverage for certain claims which is provided by independent carriers and is subject to annual coverage limits. Professional liability policies are on a claims-made basis and must be renewed or replaced with equivalent insurance if claims incurred during its term, but asserted after its expiration, are to be insured.

 
     (c)  Lease Agreements

      We are obligated under capital leases covering certain office equipment that expires at various dates during the next five years. At December 31, 2003 and 2002, the gross amount of office equipment and related accumulated amortization recorded under capital leases was as follows:

                 
2003 2002


Equipment
  $ 17,268     $ 11,291  
Less accumulated amortization
    7,794       2,857  
     
     
 
    $ 9,474     $ 8,434  
     
     
 

      Amortization of assets held under capital leases is included with depreciation expense.

      We also lease office space under operating leases which expire at various dates through 2019. Future minimum payments by year and in the aggregate under all non-cancelable leases are as follows at December 31, 2003:

                   
Capital Leases Operating Leases


2004
  $ 4,794     $ 8,309  
2005
    3,589       8,234  
2006
    1,675       7,893  
2007
    868       6,941  
2008
    408       4,895  
Thereafter
          26,576  
     
     
 
 
Total minimum lease payments
    11,334     $ 62,848  
             
 
Less amount representing interest
    (816 )        
     
         
 
Present value of minimum lease payments
    10,518          
Less: Current installments of obligations under capital leases
    (4,373 )        
     
         
 
Obligations under capital leases, excluding current installments
  $ 6,145          
     
         

      In connection with our acquisition of PHP effective January 1, 2003, AMERIGROUP Corporation agreed to guarantee a certain lease for office space occupied by a business operated by former management of PHP. Minimum lease payments under the guaranteed lease as of December 31, 2003 are $676 and $168 in 2004 and 2005, respectively. The fair value of the stand ready obligation under the guarantee is $34 and has been reflected

67


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

in the December 31, 2003 consolidated balance sheet. If the lessee defaults due to non-payment, all future rental payments are accelerated, subject to our right to cure, by bringing the payments up to date. The lease term ends in March 2005.

      Total rent expense for all office space and office equipment under non-cancelable operating leases was approximately $8,187, $5,459 and $3,476 in 2003, 2002 and 2001, respectively, and is included in selling, general and administrative expenses in the accompanying Consolidated Income Statements.

 
     (d)  Deferred Compensation Plans

      Our employees have the option to participate in a deferred compensation plan sponsored by the Company. All full-time and most part-time employees of AMERIGROUP Corporation and subsidiaries may elect to participate in this plan. This plan is exempt from income taxes under Section 401(k) of the Internal Revenue Code. Participants may contribute a certain percentage of their compensation subject to maximum federal and plan limits. We may elect to match a certain percentage of each employee’s contributions up to specified limits. For the years ended December 31, 2003, 2002 and 2001, the matching contribution under the plan in total was $720, $794 and $389, respectively.

      During 2003, we added a long-term cash incentive award designed to retain certain key executives. Each eligible participant is assigned a cash target, the payment of which is deferred for three years. The amount of the target is dependent upon the participant’s performance against individual major job objectives in the first year of the program. The target award amount is funded equally over the three year period, with the funding being dependent upon the Company meeting its financial goals each year. An executive is eligible for payment of a long-term incentive earned in any one year only if the executive remains employed with the Company and is in good standing at the beginning of the third following year. The funding for the long-term cash incentive award was $1,326 at December 31, 2003 and was included in accrued expenses, capital leases and other current liabilities.

 
     (e)  Legal Proceedings

      On July 18, 2002, Texas Children’s Hospital (TCH) in Houston filed suit in State District Court against AMERIGROUP Texas, Inc., our Texas subsidiary, seeking to be paid full-billed charges for all services rendered to our Texas subsidiary’s Medicaid members since October 1999. Our Texas subsidiary does not have a contract with TCH to provide services to its Medicaid members. When TCH provides services to our members, it does so as a non-network provider. On January 17, 2003, the physicians of Baylor College of Medicine (Baylor), non-network providers who provide medical services at TCH, filed suit against our Texas subsidiary seeking full-billed charges for services provided since October 1999 to our Texas Medicaid members. On July 7, 2003, TCH and Baylor added AMERIGROUP Corporation as an additional defendant to the lawsuits, alleging that we are directly liable for the obligations of our Texas subsidiary. The trial court ruled in November 2003 to abate the lawsuit pending TCH’s exhaustion of its administrative remedies with the Texas Health and Human Services Commission (HHSC). To our knowledge TCH has not initiated an administrative complaint in accordance with the court’s order. However, in March 2004 we received notice that HHSC had commenced a review of certain claims payment issues raised by TCH in early 2002 and which are part of the subject matter of the lawsuit.

      In May 2002, Capital Health Systems (Capital) in New Jersey filed an action in the Superior Court of New Jersey (the Court) against AMERIGROUP New Jersey, Inc., our New Jersey subsidiary, seeking to be paid full-billed charges for all services rendered to our New Jersey subsidiary’s Medicaid members since January 1, 2002. Our New Jersey subsidiary has not had a contract with Capital to provide services to its Medicaid members since December 31, 2001. As a result, services provided by Capital to our members since January 1, 2002 have been provided as a non-network provider. Capital asserts that our New Jersey subsidiary agreed to pay full-billed charges upon the expiration of our contract with them on December 31, 2001. The Court ruled in favor of Capital on August 8, 2003, and determined that our New Jersey subsidiary entered into a new contract with Capital as of

68


Table of Contents

AMERIGROUP CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

December 31, 2001. Capital filed a notice of motion for summary judgment on damages on September 12, 2003, seeking approximately $8.5 million. Capital’s motion was denied on December 5, 2003. We have petitioned the Appeals Court of New Jersey for leave to file an appeal of the Court’s summary judgment on the issue of liability. The petition is currently pending before the appellate division. Once a determination of damages is made, we intend to appeal the ruling.

      We believe in both cases that we have paid the providers in an appropriate manner. We have recorded in our financial statements amounts that represent our best estimates of outcomes that are reasonably probable. There can be no assurances that the ultimate outcome of either or both of these matters will not be materially different and could have a material effect on our consolidated financial position, results of operations, or liquidity.

 
     (f)  Purchase Obligations

      Under certain contracts, we are committed to spend approximately $8,600 on software licensing and implementation expenses for our new claims payment system and leasehold improvements relating to a new building under construction in Virginia Beach, Virginia that we will begin leasing in 2004.

 
(13) Employee Stock Purchase Plan

      On February 15, 2001, the Board of Directors approved and we adopted an Employee Stock Purchase Plan. All employees are eligible to participate except those employees who have been employed by us less than 90 days, whose customary employment is less than 20 hours per week or any employee who owns five percent or more of our common stock. Eligible employees may join the plan every six months. Purchases of common stock are priced at the lower of the stock price less 15% on the first day or the last day of the six month period. We have reserved for issuance 600,000 shares of common stock. We issued 35,039 and 52,706 shares under the Employee Stock Purchase Plan in 2003 and 2002, respectively.

 
(14) Quarterly Financial Data (unaudited)
                                 
Three months ended

2003 March 31 June 30 September 30 December 31





Premium revenue
  $ 389,562     $ 392,331     $ 411,277     $ 422,338  
Health benefits expenses
    317,298       310,536       328,235       339,831  
Selling, general and administrative expenses
    44,070       46,945       46,781       49,060  
Income before income taxes
    23,570       30,265       30,911       29,169  
Net income
    13,694       17,977       18,185       17,468  
Diluted net income per share
    0.63       0.82       0.81       0.69  
Weighted average number of common shares and dilutive potential shares outstanding
    21,631,779       21,909,649       22,328,879       25,336,292  
                                 
Three months ended

2002 March 31 June 30 September 30 December 31





Premium revenue
  $ 270,842     $ 276,821     $ 297,025     $ 307,948  
Health benefits expenses
    223,001       221,481       240,407       248,702  
Selling, general and administrative expenses
    29,921       32,318       33,927       37,243  
Income before income taxes
    16,986       21,662       21,102       19,972  
Net income
    9,886       12,916       12,450       11,784  
Diluted net income per share
    0.47       0.60       0.58       0.54  
Weighted average number of common shares and dilutive potential shares outstanding
    21,244,538       21,493,134       21,478,501       21,661,514  

69


Table of Contents

INDEPENDENT AUDITORS’ REPORT

The Board of Directors

AMERIGROUP Corporation

      Under date of February 11, 2004, we reported on the consolidated balance sheets of AMERIGROUP Corporation and subsidiaries as of December 31, 2003 and 2002, and the related consolidated income statements and statements of stockholders’ equity and cash flows for each of the years in the three-year period ended December 31, 2003, which are included herein. In connection with our audits of the aforementioned consolidated financial statements, we also audited the related financial statement schedule, Schedule II — Schedule of Valuation and Qualifying Accounts, which is also included herein. This financial statement schedule is the responsibility of the Company’s management. Our responsibility is to express an opinion on the financial statement schedule based on our audits.

      In our opinion, the financial statement schedule, Schedule II — Schedule of Valuation and Qualifying Accounts, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

/s/ KPMG LLP

February 11, 2004

Norfolk, Virginia

70


Table of Contents

SCHEDULE OF VALUATION AND QUALIFYING ACCOUNTS

                                 
Additions- Deductions-
Balance Amounts Amounts
Beginning Charged to Credited to Balance End
Valuation Allowance on Deferred Tax Assets of Year Expenses Expenses of Year





Year Ended December 31, 2003
  $ 785     $     $ 785     $  
Year Ended December 31, 2002
          785             785  
Year Ended December 31, 2001
                       
 
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

      None.

 
Item 9A. Controls and Procedures

      (a) Evaluation of Disclosure Controls and Procedures.

      Our Chief Executive Officer and Chief Accounting Officer have evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-14(c) and 15d-14(c) under the Securities Exchange Act of 1934 as amended) as of a date within 90 days of the filing date of this annual report (the “Evaluation Date”). Based on such evaluation, our Chief Executive Officer and Chief Accounting Officer have concluded that, as of the Evaluation Date, our disclosure controls and procedures are effective in alerting them on a timely basis to material information relating to AMERIGROUP (including its consolidated subsidiaries) required to be included in our reports filed or submitted under the Securities Exchange Act of 1934, as amended.

      (b) Changes in Internal Controls.

      Since the Evaluation Date, there have not been any significant changes in our internal controls or in other factors that could significantly affect such controls.

PART III.

 
Item 10. Directors and Executive Officers of the Company

      The information regarding compliance with Section 16(a) of the Securities and Exchange Act of 1934 is incorporated herein by reference from the section entitled “Section 16(a) Beneficial Ownership Reporting Compliance” of our definitive Proxy Statement (the “Proxy Statement”) to be filed pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended, for our Annual Meeting of Stockholders to be held on Wednesday, May 12, 2004. The Proxy Statement will be filed within 120 days after the end of our fiscal year ended December 31, 2003.

      The information regarding Executive Officers is contained in Part I of this Report under the caption “Executive Officers of the Company.”

      The information regarding directors is incorporated herein by reference from the section entitled “PROPOSAL #1: ELECTION OF DIRECTORS” in the Proxy Statement.

      The information regarding the Company’s code of ethics is incorporated herein by reference from the section entitled “Corporate Governance” in the Proxy Statement.

 
Item 11. Executive Compensation

      Information regarding executive compensation is incorporated herein by reference from the section entitled “Executive Officer Compensation” in the Proxy Statement.

71


Table of Contents

 
Item 12. Security Ownership of Certain Beneficial Owners and Management

      Information regarding security ownership of certain beneficial owners and management is incorporated herein by reference from the sections entitled “Security Ownership of Certain Beneficial Owners and Management” in the Proxy Statement.

Securities Authorized for Issuance under Equity Compensation Plans

                         
Number of Weighted- Number of securities
securities to be average exercise remaining available for
issued upon price of future issuance under
exercise of outstanding equity compensation
outstanding options, plans (excluding
options, warrants warrants and securities reflected in
and rights rights the first column)(1)



Equity compensation plans approved by security holders
    2,682,732     $ 20.93       1,824,133  
Equity compensation plans not approved by security holders
                 
Total
    2,682,732     $ 20.93       1,824,133  
     
     
     
 


(1)  Includes a total of 1,311,878 shares not yet issued as of December 31, 2003 under the 1994 Stock Plan, the 2000 Equity Incentive Plan and the 2003 Equity Incentive Plan and 512,255 shares not yet issued under the Employee Stock Purchase Plan.

      In 2003, we issued options to purchase 1,148,673 shares of common stock to employees. All of these options were granted under AMERIGROUP’s 2000 Equity Incentive Plan.

 
Item 13. Certain Relationships and Related Transactions

      Information regarding certain relationships and related transactions is incorporated herein by reference from the section entitled “Certain Relationships and Related Transactions” in the Proxy Statement.

 
Item 14. Principal Accountant Fees and Services

      Information regarding principal accountant fees and services is incorporated herein by reference from the section entitled “Proposal #2: APPOINTMENT OF INDEPENDENT AUDITORS” in the Proxy Statement.

PART IV.

 
Item 15. Exhibits, Financial Statement Schedules and Reports on Form 8-K

      (a)(1) Financial Statements.

      The following financial statements are filed: Independent Auditors’ Report, Consolidated Balance Sheets, Consolidated Income Statements, Consolidated Statements of Stockholders’ Equity, Consolidated Statements of Cash Flows, and Notes to Consolidated Financial Statements.

      (a)(2) Financial Statement Schedules.

      The following financial statement schedule is filed: Schedule of Valuation and Qualifying Accounts

      (b) Reports on Form 8-K.

      We furnished a report on Form 8-K on February 17, 2004, announcing our earnings for the three and twelve months ended December 31, 2003.

      We filed a report on Form 8-K on November 12, 2003, disclosing an update to litigation involving our Texas subsidiary (See Part II, Item 1. Legal Proceedings).

72


Table of Contents

      We furnished a report on Form 8-K on October 30, 2003, announcing our earnings for the three and nine months ended September 30, 2003.

      (c) Exhibits.

      The following exhibits, which are furnished with this annual report or incorporated herein by reference, are filed as part of this annual report.

         
Exhibit
Number Description


  3 .1   Amended and Restated Certificate of Incorporation of the Company (incorporated by reference to exhibit 3.1 to our Registration Statement on Form S-3 (No. 333-108831)).
  3 .2   By-Laws of the Company (incorporated by reference to exhibit 3.2 to our Registration Statement on Form S-3 (No. 333-108831)).
  4 .1   Form of share certificate for common stock (incorporated by reference to exhibit 4.1 to our Registration Statement on Form S-1 (No. 333-347410)).
  4 .2   AMERIGROUP Corporation Second Restated Investor Rights Agreement, dated July 28, 1998 (incorporated by reference to exhibit 4.2 to our Registration Statement on Form S-1 (No. 333-347410)).
  10 .6.2   Amendments to Amended and Restated Contract between State of New Jersey, Department of Human Services, Division of Medical Assistance and Health Services and AMERIGROUP New Jersey, Inc., dated October 1, 2003.
  10 .6.3   Amendments to Amended and Restated Contract between State of New Jersey, Department of Human Services, Division of Medical Assistance and Health Services and AMERIGROUP New Jersey, Inc., dated November 1, 2003.
  10 .6.4   Amendments to Amended and Restated Contract between State of New Jersey, Department of Human Services, Division of Medical Assistance and Health Services and AMERIGROUP New Jersey, Inc., dated November 1, 2003.
  10 .23.1   Amendment No. 8, to the 2002 Contract for Services between the HHS and HMO (Childrens Health Insurance Program Agreement), dated September 1, 2002.
  14 .1   Code of Ethics for Executives and Senior Financial Officers.
  21 .1   List of Subsidiaries
  23 .1   Consent of KPMG LLP, Independent Accountants, with respect to financial statements of the registrant.
  31 .1   Certification of Chief Executive Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002, dated March 9, 2004.
  31 .2   Certification of Chief Accounting Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002, dated March 9, 2004.
  32     Certification of Chief Executive Officer and Chief Accounting Officer pursuant to Section 906 of Sarbanes- Oxley Act of 2002, dated March 9, 2004.

73


Table of Contents

SIGNATURES

      Pursuant to the requirements of Section 13 or 15(d) of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Virginia Beach, Commonwealth of Virginia, on March 9, 2004.

  AMERIGROUP CORPORATION

  By:  /s/ KATHLEEN K. TOTH
 
  Name: Kathleen K. Toth
  Title: Executive Vice President and
  Chief Accounting Officer
  (principal accounting officer)

      Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

             
Signatures Title Date



 
/s/ JEFFREY L. MCWATERS

Jeffrey L. McWaters
  Chairman, Chief Executive Officer and President   March 9, 2004
 
/s/ KATHLEEN K. TOTH

Kathleen K. Toth
  Chief Accounting Officer   March 9, 2004
 
/s/ CARLOS A. FERRER

Carlos A. Ferrer
  Director   March 9, 2004
 
/s/ WILLIAM J. MCBRIDE

William J. McBride
  Director   March 9, 2004
 
/s/ UWE E. REINHARDT, PH.D.

Uwe E. Reinhardt, Ph.D.
  Director   March 9, 2004
 
/s/ RICHARD D. SHIRK

Richard D. Shirk
  Director   March 9, 2004
 
/s/ JEFFREY B. CHILD

Jeffrey B. Child
  Director   March 9, 2004

74